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“Life is a lesson, you learn it when you’re through!” 
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1. Abbreviations 
 
 
Å Ångström (internationally unit of length equal to 0.1 nanometre) 
Am Adult Male 
Aw Adult Female 
BA Bacillary Angiomatosis 
bep Bartonella Translocated Effector-proteins 
BFP Bundle-Forming-Pili 
BPH Bacillary Peliosis Hepatis 
CSD Cat Scratch Disease 
Ct Threshold Value 
dNTP DesoxyNucleoside-TriPhosphate 
EDTA EthyleneDiamineTetraAcetic 
ELISA Enzyme-Linked Immunosorbent Assay 
Eppi Eppendorf Tube 
FAM 6-Carbox-Fluorescein 
FRET Fluorescence Resonance Energy Transfer 
GFP Green Fluorescent Protein 
IF-Test Immunofluorescence Test 
IIF Indirect Immunofluorescence 
kDa Kilo-Dalton 
M Marker, Step Ladder 
LAN Linker Arm Nucleotide 
MM Master-Mixture 
mya Million Years Ago 
NC Negative Control 
NaOAc Sodium Acetate 
Rho Signalling Protein of the Rho Family 
RT Room Temperature 
T1SS Type One Secretion System 
Ta Annealing Temperature 
TAE Tris Acetate EDTA Buffer 
  
 
 
Page  2 
 
  
TAMRA 6-Carboxy-Tetramethyl-Rhodamin 
Tm Melting Temperature 
VEGF Vascular Endothelial Growth Factor 
VirB/VirD4/bep Pathogenicity Island (PAI) of B. henselae and B. quintana 
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2. Abstract 
 
DETECTION OF PATHOGENIC BARTONELLA SPECIES IN AUSTRIAN IXODES 
RICINUS TICKS 
 
Bartonella species are aerobic, Gram negative, facultative intracellular bacteria, which cause 
a variety of human and non-human diseases. They are pleomorphe, slightly curved rods 
belonging to the alpha-2 subgroup of the class Proteobacteria. Until now 24 Bartonella 
species have been described. At least 9 are pathogens for humans. They can cause Cat-scratch 
Disease, Carrion's disease, Trench fever, Bacillary angiomatosis and Endocarditis. Ticks are 
one main vector for Bartonella species. Therefor high-risk group like hunters and foresters 
should be emphasized. Further, Bartonella vectors beside ticks are cat fleas, sand flies and 
clothes louses. 
In this study 4 strains of Bartonella (B. clarridgeiae, B. grahamii, B. henselae, and B. 
doshiae) were cultivated and used as positive controls for the design of a Bartonella specific 
PCR. Two different PCRs were established: a Bartonella specific one and one for species 
differentiation. Therefor two target sequences were chosen: the 16S rRNA gene and the 16-
23S intergenic spacer region, whereas the primers for the ITS region were used for species 
differentiation. With these Bartonella PCRs a tick library has been screened. The tick library 
consists of 10.326 Ixodes ricinus ticks (adults, nymphs and larvae) collected at different 
locations in Austria. This screening was performed with two different PCR assays: a Real 
Time PCR and a Nested PCR. The results and the two analysing methods have been 
compared to each other. 
In further studies two libraries of human sera have been screened for antibodies to Bartonella 
by an immuno fluorescence test (IIF-Test for B. henselae and B. quintana IgG, Euroimmun 
Biochip Kit). The first library consists of 891 hunter sera of the year 2002 and the second 
library was used as a reference consisting of 624 sera from blood donors to the red cross of 
the year 2006. 
 
The screening of 216 tick samples, 24 samples of each province in Austria consisting of 8 
Adults, 8 Nymphs and 8 Larvae, resulted in an infection rate of 7.4 in the case of the Real 
Time PCR and 10.7% for the Nested PCR. 
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Furthermore the results showed that the rate of infection increases from larva stage to adult 
ticks! 
The established differentiation PCR with the target sequence 16-23S intergenic spacer region 
showed good results with the different Bartonella positive controls but no results could be 
obtained for the screened positive tick samples. 
The indirect immuno fluorescence screening with the EUROIMMUN Kit for IgG antibodies 
against Bartonella henselae and B. quintana resulted in a slightly higher rate of infection 
within the hunters as high risk group. 13.5% seropositive of the Hunter serum library and 
11.5% of the Blood donors (Red Cross) serum library. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Page  5 
 
  
3. Introduction 
3.1. Bartonellaceae 
3.1.1. Historical overview of the family Bartonellaceae 
3.1.1.1. Bartonella bacilliformis 
 
All started with the outbreak of an epidemic in the year 1540, which was caused by 
Bartonella bacilliformis. Conquistador Miguel de Estete described it as an epidemic with a 
biphasic process. So possibly it is the oldest described epidemic. But it took 365 more years 
till the species was described by Dr. Alberto Barton (Fig. 1) in 1905 [32]. To his honor the 
organism was named Bartonella bacilliformis, the agent of the Carrións disease. The course 
of the disease is biphasic starting with the Oroya fever followed by the chronicle second 
phase, the Verruga peruana (Fig. 2) which are vasculoproliferative lesions of the skin [1]. 
Furthermore typical morphological changes of a Verruga peruana were found in a re-
hydrogenated mummy of the Inca-time [2]. This finding is a proof that this disease has existed 
in this region for hundreds of years. 
 
   
 Fig. 1 Dr. Alberto Barton Fig. 2 Verruga Peruana 
 
Many decades the family of the bartonellaceae consisted of only one species: Bartonella 
bacilliformis. This endemic pathogen can be found in the river valleys and canyons of the 
South-American Andes Mountains. The bacteria are transmitted through blood-sucking 
female sand flies of the genus Lutzomya verrucarum. These flies inhabit the Andes Valleys 
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between 500 and 3.000 meters elevation [3]. Especially in Peru and Colombia outbreaks of 
this disease could have been observed. 1870, short after the foundation of the republic of Peru 
the then government decided to build a railroad from the capital city Lima to the 5.000 meters 
higher situated mine settlement La Oroya. Therefor 10.000 workers from Chile and the 
coastal cities of Peru were engaged. This people came from a region where the Carrións 
disease was totally unknown. In the course of the construction work, especially in the area 
near the Rimac river, 8.000 people fell ill and died cause of high fever and severe anaemia. 
This phase of the disease was therefore called Oroya fever. Workers which survived the fever 
developed weeks to month later wart like skin disorders, called “verruga peruana” [5]. Then 
in August of the year 1885 a 26 year old medical student with the name Daniel Alcides 
Carrión wanted to prove with a self-experiment that the Oroya fever and the Verruga peruana 
are caused by the same pathogen. He inoculated secretion obtained of the skin lesion of a 14 
year old Verruga peruana patient. 21 days after the inoculation Carrión sickened with high 
fever and a severe anaemia. 18 days later, on the 5
th
 October 1885 he passed away [5]. To 
honor his heroic act the as “Bartonelloses” long known disease was also called “Carrión-
disease”. 
With the knowledge of the vector for Bartonella bacilliformis a try was made to exterminate 
the sand flies in the endemic areas. The result was that sand flies could have been found in 
other regions with a higher density. As a consequence, in this endemic free areas endemics 
emerged [5, 6]. The last endemic was in the year 1998 in the region Urubamba in Peru [7]. 
 
 
3.1.1.2. Bartonella quintana 
 
The next newly described Bartonellaceae was Bartonella quintana in 1917 by Schmincke [26] 
and Henry da Rocha Lima [11]. Schmincke named it Rickettsia quintana and da Rocha Lima, 
a Brazilian microbiologist, Rickettsia pediculi. When the bacterium was divided from 
Rickettsia, as an honor of da Rocha Limas work, it was named Rochalimaea quintana [27]. 
Finally in the year 1993 it was reassigned to the family Bartonellaceae with the name 
Bartonella quintana [25]. It’s the agent which causes trench fever, bacillary angiomatosis and 
endocarditis. Trench fever was the first clinical manifestation of a Bartonella infection to be 
recognized. The name “trench fever” was coined because the disease came to prominence as 
an infection of troops in both the German and Allied armies during World War I. The troop 
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physicians His and Werner independently described a cyclic feverish progress of the disease. 
It was located in Wolhynia, a region in what is today Ukraine [8]. The disease was 
characterized by a 5-day relapsing fever, with severe and persistent pain in the shins, and 
although rarely fatal, it resulted in prolonged disability. It has been estimated that trench fever 
affected over 1,000,000 people [9]. The disease was named Five day fever (Werner) or 
Wolhynia fever (His). But it is also known under the name Werner-His disease or Trench 
fever [10, 11]. Under these victims of World War I also J.R.R. Tolkien (John Ronald Reuel 
Tolkien) could be found [12]. 
 
Short abstract of John Garth’s book Tolkien and the Great War: The Threshold of Middle-
earth: 
“He writes that when war broke out, Tolkien was active in an Oxford 
literary society known as the Tea Club and Barrovian Society (TCBS), 
along with three of his closest friends. Finishing his degree before joining 
up, Tolkien served as a signal officer in the nightmarish Battle of the Somme 
in 1916, where two of those friends were killed. The ordeal on the Somme 
led to trench fever, which sent him home for the rest of the war and 
probably saved his life. It also influenced a body of Northern European-
flavored mythology he had been inventing and exploring in both prose and 
verse before the war, toward its evolution into The Book of Lost Tales and 
in due course Lord of the Rings and The Silmarillion. This book could not 
pretend to be aimed at other than the serious student of Tolkien, and 
readers will benefit from a broad knowledge of his work (as well as a more 
than casual knowledge of WWI). But it also argues persuasively that Tolkien 
did not create his mythos to escape from or romanticize the war. Rather, the 
war gave dimensions to a mythos he was already industriously exploring.” 
 
Although cases of trench fever were simultaneously reported on two fronts, the disease was 
supposedly conveyed from the eastern front to the western front by German soldiers in 1914 
having been originally acquired from endemically infected Russian populations [10, 13, 14, 
15]. Cause of the transferral of British troops to Mesopotamia and Salonika the disease was 
carried with them and spread in these regions [16, 17]. Subsequent investigations revealed 
that the Trench fever was known since the Middle Ages [10]. In Northern Ireland in the first 
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half of the nineteenth century [18] and also in Russia [14] a similar disease was described. 
After World War I cases have been monitored in Spain, Sweden, Ukraine, Georgia and Russia 
[10]. After the conclusion of the war, the incidence of trench fever and thus medical interest 
in the condition fell dramatically. But during World War II the disease reemerged and 
German troops [10] spread it throughout Norway, Finland [19] and Yugoslavia [20]. The next 
diseases have been monitored in Algeria, Egypt, Ethiopia, Japan, China and Mexico [13]. The 
recent outbreak was described in Burundi 1997 [21]. 
 
 
3.1.1.3. Bartonella henselae 
 
The next big step was the identification of Bartonella henselae [22]. The first evidence of a 
new Bartonella species was provided by Dr. Relman in 1990. He managed to identify the 
pathogen which causes Bacillary Angiomatosis as a close relative of Bartonella quintana 
[23]. Almost at the same time Dr. Slater isolated a bacterium out of the blood sample of an 
immunosuppressed patient and also related it as a close relative to Bartonella quintana [24]. 
Finally Welch and colleagues isolated the bacterium from a (HIV)-infected patient with BA, 
septicaemia and parenchymal peliosis. They characterized and named it Rochalimaea 
henselae [22] which was renamed to Bartonella henselae and incorporated to the family 
bartonellaceae [25]. The species is spread worldwide. In cats it causes an asymptotic 
intraerythrocytic bacteremia. The disease transmission to humans happens through bites or 
scratches of cats and can also be transmitted through cat-fleas [28, 29]. Beside this disease, 
named cat scratch disease, Bartonella henselae can cause bacteremia and endocarditis. This 
involves immunocompromised as well as immunocompetent patients [30, 31]. 
 
 
3.1.2. Phylogeny of the genus Bartonella (formerly known as 
Rochalimaea) 
 
Bartonella belong to the phylum proteobacteria. They are assigned to the class α2 
proteobacteria, the order rhizobiales and the family bartonellaceae. The next kinships are 
Brucella abortus and Agrobacterium tumefaciens which are also counted among the order 
rhizobiales. Until now 24 Bartonella species and 3 subspecies have been described. At least 9 
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are pathogens for humans (Tab. 1). The last member of the genus Bartonella, B. melophagi is 
such a newly discovery that its name has yet to be formally accepted. So the genus Bartonella 
consists of 2 human specific species, 6 zoonotic species and 15 animal specific ones. The last 
two members have not been assigned to one of this groups until know. But in the case of B. 
melophagi, which was found in human blood samples, it is assumed to have potentials as a 
pathogen to humans. 
 
The best markers which are used for detection and differentiation of Bartonella species are 
16S rRNA, ribC (riboflavin synthase) gltA (citrate synthase), rpoB (beta subunit of RNA 
polymerase), 16-23s ITS (intergenic transcribed spacer region), groEL (heat shock protein), 
and ftsZ (cell division protein) sequences. This different target sequences were used for the 
comparison of neighbour-joining trees (Fig. 3 [52]). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Page  10 
 
  
 
 
Tab. 1 List of so far known Bartonella species (effective 2009) 
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Fig. 3 Comparison of neighbour-joining trees based on 16S rDNA, gltA, rpoB, ITS, groEL, and ftsZ partial or 
complete sequences. Bootstrap values at tree nodes are based on 100 replicates; values of 90 are boldfaced. Trees 
were unrooted, and only topology was shown for these trees.  
a, gltA, citrate synthase; rpoB, beta subunit of RNA polymerase; ITS, 16S–23S rRNA ITS; groEL, heat shock 
protein; ftsZ, cell division protein. 
b, range of the level of DNA sequence similarity for each gene used. Designations for species and subspecies 
consist of the letter B (for Bartonella) 
and the following abbreviations: ber, vinsonii subsp. berkhoffii; vin, vinsonii subsp. vinsonii; aru, vinsonii subsp. 
arupensis; tri, tribocorum; eli, elizabethae; gra, grahamii; tay, taylorii; als, alsatica; dos, doshiae; hen, henselae; 
qui, quintana; koe, koehlerae; cla, clarridgeiae; bir, birtlesii; sho, schoenbuchensis; bac, bacilliformis; bov, bovis 
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3.1.3. Biological characteristics of Bartonellaceae 
 
Bartonella are spread worldwide. They are aerobic, Gram negative, facultative intracellular 
bacteria, which cause a variety of human and non-human diseases. These parasites can also 
infect healthy people but are considered especially important as opportunistic pathogens. 
They are pleomorphe, slightly curved rods with a size of 0.2-0.5 μm x 1.7-2.2 μm. 
Biochemical Bartonellaceae cannot convert glucose and indole. They are oxidase-, urease- as 
well as catalase- negative. Their genome size is between 1600 and 2100kb [53, 54, 55]. 
In culture Bartonellaceae grow very slow and need a complex medium with hemin added [56, 
57]. The best growth results can be achieved in co-culture with endothelial cells. Easier and 
very effective too is the cultivation on Columbia blood agar plates. The medium consists of 
5% sheep- or rabbit- blood and is incubated at 35 °C to 37°C (in the case of B. bacilliformis at 
30°C) and a CO2 concentration of 5%. Furthermore it is beneficial to use a water vapour 
saturated atmosphere. In primary cultures the grey to white colonies appear after 6 to 21 days 
in comparison to subcultures. There the first colonies can be found after 3 to 4 days [58].  
 
 
3.1.4. Distribution and Reservoir 
 
Bartonellaceae are spread worldwide with different core areas for the particular species (Tab. 
2). Especially Bartonella bacilliformis and B. rochalimae can only be found in South 
America. 
A further factor for this diverse distribution is the wide range of different reservoirs and 
vectors (Tab. 1). Most Bartonella species colonise the blood of different mammals. Cats and 
dogs, cattle and sheep as companion animals, mice and rats in close proximity to humans as 
well as moles, voles and deer are counted among this different reservoir mammals. So it 
seems that most of these Bartonella species have a defined and very tight host spectrum they 
colonise. So this specificity for the host or vector may explain the current geographic 
distribution of Bartonella species. 
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Species  Distribution  
B. alsatica Europe  
B. bacilliformis  South America  
B. bovis  Europe, Africa, North America  
B. clarridgeiae  Europe, USA, Asia  
B. doshiae  Europe  
B. elizabethae  Europe, USA, Asia  
B. grahamii  Europe, Canada, Asia  
B. henselae  South America, Europe, USA, Africa, Asia  
B. koehlerae  USA  
B. quintana  South America, Europe, USA, Africa  
B. rochalimaea  Peru  
B. taylorii  Europe  
B. vinsonii subsp. berkhoffii  Europe, USA  
B. washoensis  USA  
Tab. 2 Overview of the geographical distribution of Bartonella species 
 
 
3.1.5. Infection of the reservoir host 
 
Most of the Bartonella species colonize the blood of various mammals. Using the example of 
Schulein et al. Bartonella tribocorum – model the course of the infection could have been 
described very detailed [59, 60]. They infected Wistar rats through an intravenous injection 
with Bartonella tribocorum. After the injection it took only some hours so that all culturable 
organisms were cleared from the circulating blood. In addition the blood remained sterile for 
3 to 4 days. It’s unknown which kind of primary niche Bartonella is using in this time. It 
could be possible they use vascular endothelial cells as primary niche or other authors believe 
the bone marrow is likely [61]. After 4 to 5 days post inoculation (d.p.i.) the bacteremic phase 
started. The bacteria associated with circulating mature erythrocytes and subsequently 
invaded them (Fig.4). The next phase witch immediately follows the invasion process is the 
intracellular replication. From this state on Bartonellae persist for weeks within the 
erythrocytes and thereby increasing their chances for transmission by blood-sucking 
arthropods. The cessation of the bacteremia is an antibody-dependent process [62] 
In contrary to infections of humans witch result in an illness the course of infection of the 
animal host mostly shows a long lasting, asymptomatic bacteremia. This hypothesis could 
have been proven through cat [63], rat [59] and mouse [62] experiments. 
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Fig. 4 Model of erythrocyte parasitism by Bartonella spp. [59] 
 
Further studies on the course of Bartonella infections of the reservoir host were performed of 
the research groups Kosoy [64], Bermond [39] and Boulouis [65]. 
 
 
3.1.6. Pathogeneses 
 
So the colonization of an organism with Bartonella can result in different kind of reactions: 
the asymptotic colonization in animal hosts on the one side and the acute or chronic disease 
upon the colonization of man on the other side. This is possible because Bartonella possess 
several very fascinating properties for pathogeneses. Two of these pathogenicity mechanisms 
are apparent: the invasion of endothelial cells and induction of neoformation of capillaries 
(angiogenesis) and the possibility of the invasion of mature human erythrocytes.  
The invasion of endothelial cells and induction of angiogenetic processes is known for B. 
baciliformis, B. henselae and B.quintana [66, 67, 68, 69, 70, 71]. It could have been shown 
that the mechanism for the invasion of the endothelial cells was a bacterial-induced 
endocytosis. A second capability is the invasome-mediated internalisation of the bacterium 
into the endothelial cell. This is a unique process which has until now only been observed for 
B. henselae. The bacteria interact with endothelial cells resulting in bacterial aggregation on 
the cell surface and the subsequent engulfment and internalisation of the bacterial aggregate 
by the invasome structure. So the bacteria have the capability to restructure the actin-
cytoskeleton for the internalisation [67, 68]. There are at least 5 membrane-proteins of B. 
henselae which can bind to endothelial cells [72].  
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After the invasion this 3 mentioned Bartonellaceae have the capability to induce proliferation 
of endothelial cells [73, 74, 69, 71]. This ability seems to be VEGF (“vascular endothelial 
growth factor”) mediated and Rho dependent. Furthermore the anti-apoptotic activity of 
Bartonella can play a role in the VEGF mediated suppression of the caspase-activity and 
DNA-fragmentation [71, 75]. The clinically manifestation of endothelial cell proliferation is 
the Bacillary Angiomatosis, Veruruga peruana [1, 2, 5] and Peliosis hepatis. 
 
 
3.1.6.1. The erythrocyte-invasion of Bartonella 
 
A wide spread mechanism of many microorganisms to invade cells is the induction of a 
phagocytic process of the host. This process is essential for many intracellular occurring 
pathogens [76]. 
 
Beside Bartonella only some parasites like Plasmodium [77] or Anaplasmataceae [110] have 
the capability to invade mature human erythrocytes. 
Generally the most widespread mechanism of many microorganisms to invade cells is the 
induction of a phagocytic process of the host cell. Simplified the phagocytoses can be divided 
in 3 stages: the adhesion – a receptor-mediated process which results in the restructure of the 
cell-cytoskeleton, the internalisation – the engulfment with the cell-plasma membrane 
forming an endocytotic vesicle and the uptake into the cell and the evasion of the host 
defence and the escape. This principle is used of many bacteria in different ways. Even for 
Bartonella bacilliformis [73], B. henselae [67, 68] and for B. quintana [66] it could have been 
shown in vitro (for B. quintana even in vivo) that these bacteria are incorporated in various 
epithelial and endothelial cells. 
In the case of bacterial mature erythrocytes invasion there are some differences reasoned in 
the special properties of this cell type. Mature erythrocytes lack a cell nucleus and most 
organelles. So the cell can’t be stimulated to start a phagocytic process nor does it feature the 
possibility of an actin-dependent formation of endocytotic vesicles. Furthermore the 
erythrocyte-membrane (Fig. 5) shows much more stability against shearforces than other cell 
membranes [78]. 
So the question is how does Bartonella manage to invade mature erythrocytes? The first guess 
was that Bartonella invade erythroid cells. But in the case of B. tribocorum this was not 
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verified [79]. It could have been shown that not until the fourth day of the bacteremic phase B. 
tribocorum could have been found intraerythrocytic. The invasion process and the involved 
factors have yet not been sufficiently studied. 
 
 
Fig. 5 Model of an erythrocyte cell membrane 
Ankyrin - based macromolecular complex - proteins linking the bilayer to the membrane skeleton through the 
interaction of their cytoplasmic domains with Ankyrin. 
Band 3 - Anion transporter, also an important structural component of the erythrocyte cell membrane, makes up 
to 25% of the cell membrane surface, each red cell contains approximately one million copies 
 
 
3.1.6.1.1. Membrane-receptor-protein 
 
There may be is an interaction of B. bacilliformis and B. henselae with identified proteins of 
human as well as animal erythrocytes. In the human erythrocyte membrane a 230 kDa protein 
could have been found independently by two different studies. This protein, assumed to be 
spectrin, is bound by B. bacilliformis even if it’s cleaned up. Further proteins found to be 
involved were glycophorin A, glycophorin B and actin [80, 81]. So this special invasion 
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ability of B. bacilliformis seems to be attributed to a contact-dependent process [82]. Older 
postulations like of Walker and Winkler in 1981 [83] had the opinion that the binding-
structure at erythrocytes are no glycoproteins but glycolipids. 
 
 
3.1.6.1.2. Flagella, fimbriae and deformin 
 
The first big step was the detection of a stable complex between B. bacilliformis and human 
erythrocytes in vitro. It was studied through an electron microscope by Benson et al. in 1986 
[84]. B. bacilliformis as well as B. clarridgeiae and B. schoenbuchensis possess multiple 
unipolar flagella. In the case of B. bacilliformis it could have been shown that the inhibition 
of flagellin resulted in a reduced binding capability to the erythrocyte surface and an 
elimination of the invasion capability. So the 42 kDa flagellin protein which is needed to 
build flagella of B. bacilliformis is responsible for the bacterial mobility and therefore the 
formation of an aggregation [84, 85, 86, 87, 88, 89]. Since the most Bartonella species, like B. 
henselae [67], have no flagella but still invade erythrocytes there have to be further 
mechanisms for invasion. 
Some Bartonella species possess bundle-forming-pili (BFP) also known as fimbriae. For 
many other bacteria this BFP play a major role in bacterial adhesion but in the case of 
Bartonellaceae it is unexplained [87]. 
The building of aggregations of Bartonellaceae on the surface of red blood cells went along 
with structural changes of these blood cells. This discovery was made by Benson et al. and 
related to deformin [84]. It causes morphological changes of the cell surface like folds, 
invaginations and the formation of intracellular vacuoles [86]. Deformin is a hydrophobic 
factor which was isolated from B. bacilliformis and B. henselae cultures harvested of red 
blood cells. Even after the removal of the bacteria and consequently of deformin the structural 
changes of the red blood cells maintained [84]. 
Further studies showed that also purified deformin causes deformation of the erythrocyte cell 
wall [81]. First assumptions pointed to a protein-like structure [90]. In further, more actual 
studies deformin was described as a small hydrophobic molecule with the following 
properties: a molecular weight of about 1.4 kDa [91] and soluble through albumin-binding 
[70]. A possible treatment was described by Mernaugh and Ihler with Vanadate, an ATPase-
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inhibitor or the phospholipid Dilauroylphosphatidylcholine. Further on the intracellular 
calcium concentration can be increased [86]. 
 
 
3.1.6.1.3. Type IV secretion system 
 
Many microorganisms have developed various systems to transport pathogenicity factors into 
the intracellular space. These transport systems of gram negative bacteria are divided in 6 
classes: T1SS – T6SS [92, 93, 94, 95, 96]. 
The Bartonella type IV secretion systems consist of the VirB/VirD4 and the Trw system. The 
T4SS is homologous to the conjugation apparatus of bacteria and consists of several 
membrane associated and trans-membrane proteins (Fig. 6) [97-101]. 
 
 
Fig. 6: The VirB/VirD4 and Trw type IV secretion system of Bartonella [98]. 
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Of the two known Bartonella T4SS the Trw contributes to the development of an 
intraerythrocytic infection whereas VirB/VirD4 mediates a sub-function of the endothelial 
cell function [102]. 
So the Trw system is required for intraerythrocytic parasitism of Bartonella. It might not be 
required for infection of erythrocytes but rather for their colonization and/or for 
intraerythrocytic replication. The finding that the Trw system is upregulated during in vitro 
infection of erythrocyte leads to further suggestions. The bacteria might gain competence for 
subsequent erythrocyte infection during their transient inhabitation of red blood cells. [97, 
103]. 
The Bartonella VirB and VirD4 genes are highly conserved between B. henselae and B. 
quintana in which the encoding loci have been sequence-analyzed. There is also a close 
phylogenetic relationship between the AvhB/Tra conjugation system of Agrobacterium 
tumefaciens and the VirB/VirD4/bep pathogenicity island (PAI) of B.henselae and B. 
quintana (Fig. 7) [97]. In contrast the bep genes (Bartonella translocated effector-proteins) 
differ widely between Bartonella species. Similar to VirB/VirD4, BepA–BepG are required 
for invasion, proinflammatory activation and antiapoptotic protection of erythrocytes. Thus, 
BepA–BepG are likely to represent the molecular effectors mediating VirB/VirD4-dependent 
cellular responses in infected erythrocytes [97, 104]. 
 
 
Fig. 7: PAI and AvhB/Tra conjugation system. 
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3.1.7. Diseases caused by Bartonella species pathogenic to humans 
 
 
Tab. 3 Human pathogens among the Bartonella species 
 
Of the so far known 24 Bartonella species and 3 subspecies at least 9 are pathogens for 
humans (Tab. 1). The 3 most important pathogens of these 9 species are B. bacilliformis, B. 
henselae and B. quintana (Tab. 3). These Bartonella species can be transmitted by arthropods 
or by direct contact with infected mammals, and various diseases can occur after infection 
with these pathogens. Depending on the immune status of the patients the disease pattern can 
differ widely. 
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3.1.8. Diseases according to Bartonella species 
 
3.1.8.1. Bartonella bacilliformis 
 
Oroya-fever is a haemolytic disease and the first stage of the biphasic course of the Carrións 
disease caused by Bartonella bacilliformis. Transmitted through Lutzomya verrucarum 
(sandfly) the disease is endemic in the South American Andes [3]. After the infection through 
the sandfly it takes 2-14 weeks till the first symptoms appear. Oroya-fever is the acute form 
and comes along with high fever, severe haemolytic anaemia, hepatosplenomegaly, 
lymphadenopathy, paleness, tachycardia and circulatory collapse [4, 106]. The haemolytic 
anaemia is caused by the bacterial colonisation of the erythrocytes. In the acute phase 40-
100% of the erythrocytes can be infected [107, 108]. Without treatment the disease is fatal in 
40-85% of the cases. 
Patients who survive the first phase show after 2-3 month the first signs of the second stage of 
the Carrións disease; it is called Verruga peruana (Fig. 2) which presents with 
vasculoproliferative lesions of the skin [1] belonging to the vasoproliferative group of 
diseases. These lesions, wart like papules, are similar to Kaposi’s sarcoma. They emerge 
especially on the limbs and can concern the all layers of the skin [109, 13]. Three different 
forms can be differentiated: miliary nodules with 2-3mm in diameter, a few large nodules 
with a diameter of 1cm, or mular with painful, deep-seated lesions in the ankles. All of these 
forms show angioneogeneses and endothelial cell proliferation [109]. In most of the cases this 
pathological changes disappear after 1-2 month without therapy [111]. 
 
 
3.1.8.1. Bartonella clarridgeiae 
 
1995 Bartonella clarridgeiae was isolated by Clarridge et al [112] and in 1996 it was 
characterised and described by Lawson et al [33]. The first evidence that B. clarridgeiae 
causes cat scratch diseases like B. henselae was found 1997 [113]. The patient, a veterinary, 
who got bitten by a cat, fell ill with symptoms like headaches, fever and swelling of the lymph 
node. At the site of the bite a papular lesion developed. Serologically only antibodies against 
B. clarridgeiae could be found. The next case of B. clarridgeiae cat scratch disease was 
described 1998 by Margileth et al [114]. So after these and further studies it could have been 
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shown that B. clarridgeiae is like B. henselae an agent that causes CSD. Further symptoms 
are weight loss and a possible chest-wall abscess [114].
 
 
3.1.8.2. Bartonella henselae 
 
The most frequent disease caused by Bartonella species is the cat scratch disease (CSD). In 
cats it causes an asymptomatic intraerythrocytic bacteremia. The transmission of pathogens to 
humans occurs through bites or scratches of cats; they can also be transmitted through cat-
fleas [28, 29]. CSD is an inflammatory-granulomatous disease with major differences of the 
symptoms between immunocompetent and immunocompromised people. Epidemiological 
and clinical features of CSD were first described by Debré et al in 1950 [115]. The causality 
of B. henselae in CSD has since been demonstrated by serological and molecular assays [23, 
116, 117, 118, 119]. There are frequent CSD cases in North America and in Europe. 
Especially children in warm and humid areas [120, 121, 122, 123]. According to research 
studies in the USA in 1985 and 1997 the incidence rate of the disease was 9 cases per 100.000 
inhabitants per year [124, 125]. Immunocompetent adults can fall ill but in most of the cases 
the infection is subclinical and so not diagnosed. The course of a typical CSD is in general 
self-restricted and lasts approximately 2 to 3 month. Three to 10 days after the bite or scratch 
small russet papule are arising at the wounded skin-area followed by inflammatory 
lymphadenopathy and sometimes suppuration and fever. The lymph node swelling reaches its 
mean size of 5cm diameter after 2 to 3 weeks, and lymph nodes of the axillia [124] and of the 
neck [126] are most frequently affected. 
In atypical cases manifestations like oculoglandular syndrome of Parinaud, erythema 
nodosum, encephalopathy, osteolytic lesions, thrombocytopenic purpura, and erythema 
marginatum occur [124, 127]. 
In case of immunocompromised patients, like HIV-infected persons, the clinical manifestation 
is totally different and can be life-threatening [128]. Especially atypical CSD can be observed 
in immunocompromised patients [129, 130]. Beside CSD Bartonella henselae can cause two 
vasoproliferative diseases in immunocompromised persons, bacillary angiomatosis and 
bacillary peliosis [22, 131, 132, 133, 134, 135]. However, cases of bacillary angiomatosis 
have also been described in immunocompetent persons [136]. 
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The cutaneous form of bacillary angiomatosis leads to vasculoproliferative lesions of the skin. 
These are papule and vascular tumours which resemble them of verruga peruana. If these 
lesions affect the bone marrow, the liver, the spleen or lymph nodes the disease is called 
bacillary peliosis hepatis [137, 138, 139]. It’s an uncommon vascular condition characterised 
by randomly distributed multiple blood-filled cavities [140, 141, 142, 143]. 
Furthermore Bartonella henselae can cause endocarditis [144]. 
That’s in the range of the most important diseases B. henselae can cause but there are case 
reports after which practically every human organ or tissue can be affected. 
 
 
3.1.8.3. Bartonella quintana 
 
There are many names for this haemolytic pyretic disease caused by B. quintana; shinbone 
fever, five day fever, quintan fever, the most common one is trench fever. All of these names 
describe characteristics of the disease. Symptoms are arthralgia especially of the shinbone, 
fever relapsing approximately every 5 days, strong headaches, anorexia, shivering, excessive 
sweating, tachycardia and myalgia [13, 145,146, 147]. 
Especially in cases of immunocompromised patients the infection manifested as bacillary 
angiomatosis, endocarditis or unspecific fever [148, 149; 150]. 
 
 
3.1.8.4. Bartonella elizabethae, B. grahamii and B. vinsonii subsp. 
arupensis 
 
So far there are only two studies where . elizabethae was detected in humans and related to 
endocarditis [151] and neuroretinitis [152].  
With PCR methods B. grahamii was detected in ocular fluid of a patient with neuroretinitis 
[105]. Furthermore there have been indications that B. grahamii is the causative agent of 
bilateral occlusion of branches of the central artery of the retina [153]. 
Bartonella vinsonii subsp. arupensis was isolated from the blood culture of a cattleman [36]. 
The second finding was in 2003; a 79 year old man with endocarditis was tested positive for 
B. vinsonii subsp. arupensis [154]. 
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3.1.9. Diagnosis 
 
Many different genetic methods for the detection of Bartonella species have been developed 
in the last years. For instance site directed mutagenesis of B. bacilliformis [88] and B. 
tribocorum [60]. Or the construction of a suitable expression vector for protein synthesis in B. 
henselae and its use to establish green fluorescent protein (GFP) as a novel expression marker 
[155, 156]. So this emerging pathogen could be labelled in vivo by GFP and detected with 
fluorescence microscopy to study the genetics and the interactions with living host cells. 
The detection of B. bacilliformis, which causes Oroya fever, is possible by blood cultures or 
blood smears stained with Giemsa. In lesions of verruga peruana the pathogens can be 
detected through antibody or DNA tests [106, 157, 158]. 
In case of a suspected CSD caused by B. henselae (Fig. 8) serological methods like 
immunofluorescence test, ELISA, Western Blot as well as PCR tests are used [58, 118, 159, 
160, 161, 162]. The histological detection in biopsy material shows the best results with the 
Warthin–Starry silver nitrate-based staining method [163]. The cultivation of B. henselae out 
of biopsy material is a very lengthy and unreliable procedure and thus it is playing a minor 
role among diagnostics [163]. 
The diagnostic of a B. quintana infection is difficult because of its similarity to many other 
febrile diseases. So the case history of the patient is very important. Did he have been in 
endemic regions or had contact to lice. The infection can be detected serologically by 
detection of specific antibodies with IIF and Western Blot assays, microbiologically by blood 
cultures and by detection of specific nuclear sequences by PCR [106, 165, 166]. 
Similar diagnostic procedures may be helpful for the detection of infections by B. 
clarridgeiae, B. elizabethae and B. grahamii. 
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Fig. 8 Algorithm for CSD diagnosis [164] 
 
 
3.1.10. Treatment 
 
Bartonelloses are treated with antibiotics. The acute phase of Carrion´s disease is treated 
mainly with ciprofloxacin (or chloramphenicol). For verruga peruana rifampicin or 
macrolides are recommended [106, 111, 167]. B. quintana infections are treated with 
doxycycline, erythromycin or azithromycin [13, 168] and in case of an endocarditis 
additionally with aminoglycoside [169]. 
Bacillary angiomatosis caused by B. henselae is treated with erythromycin [22, 24, 148, 170]. 
CSD is most commonly treated with macrolide antibiotics such as azithromycin [125, 171]. It 
has been shown that there is a major difference between the in vivo and in vitro antibiotic 
susceptibility of Bartonella species. In vitro Bartonella are sensitive to almost every antibiotic 
tested. In vivo some antibiotics, like beta-lactams, are only poorly effective [172, 173]. In 
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order to prevent relapses the antibiotic treatment should be extended to last at least 6 weeks. 
In laboratory spontaneous resistances to antibiotics have occurred, e.g. cournemycin [174]. 
 
 
3.2. Ixodes ricinus, a possible tick vector 
 
3.2.1. Systematic and morphology 
 
The first phylogenetic tree for the ticks has been published by Hoogstraal and Aeschlimann in 
1982 based on morphology, development, karyotype, reproduction and host phylogeny [175]. 
In the 1990s first phylogenetic tick studies with molecular characters were performed. Until 
now there have been more than 30 papers on the molecular phylogeny and evolution of ticks 
[175, 176, 177]. Historically there is only little information about the tick evolution so fossil 
ticks date back only 30 to 40 mya [180]. 
Ixodes ricinus ticks belong to the phylum arthropoda. They are assigned to the class 
arachnida, the order parasitiformes, the suborder ixodida and the family ixodidae (hard ticks). 
Their common name is “gemeiner Holzbock”. These castor bean ticks are specialized as 
bloodsucking ectoparasites of mammals, birds, reptiles and amphibian [175, 178, 179]. 
The male tick is 2 – 3 mm long with a scutum on the dorsal side. It is a sclerotized carapace 
which overspreads the whole dorsal side (Fig. 9). In contrary unfed female ticks are 3 - 5 mm 
long and their scutum just covers the front part of the dorsal side. This ensures that the female 
can stretch its body during the blood meal to a size of up to 1 cm. The colour of the male is 
black-brown and of the female maroon. Fed females have a change in their colour to blue-
grey. They have cutting mandibles (chelicerae) and a feeding tube (hypostome) which is 
covered with recurved teeth used for the blood-feeding process [178, 181, 182]. 
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Fig. 9 Ixodes ricinus developmental stages: from left to right lava, nymph, adult tick male, adult tick female 
[EUCALB homepage, http://meduni09.edis.at/eucalb/] 
 
 
3.2.2. Life cycle 
 
The I. ricinus life cycle (Fig. 10) is dependent on several environmental factors like air 
temperature, atmospheric humidity and light as well as the disposability of hosts. Therefore 
the life cycle can last 2 to 6 years [181, 183]. There are 3 developmental stages and in every 
stage a blood meal is required to evolve to the next level. Out of the laid eggs six-legged 
larvae with a size of up to 0.6 mm hatch. After the blood meal it takes days to months till the 
larva moults to the nymph. The eight-legged nymph has like the adult male tick only a small 
scutum and can reach a size of up to 1 mm. After a 3 – 4 days blood meal the nymphs run 
through a gestation period of several weeks to reach the sexually mature adult stage. During 
the sucking action the female can soak up to 200-times of their normal weight in blood. In this 
time the fertilization takes place followed by the death of the male. The saturated and 
fertilized female falls of the host and lays up to 2000 eggs in the upper layers of earth before it 
dies [178, 182, 183, 184]. 
Ixodes ricinus ticks use a very wide host range, whereas larvae and nymphs prefer small 
mammals, reptiles and birds and adult ticks bigger mammals as host [185, 186, 187]. 
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Fig. 10 Ixodes ricinus life cycle [EUCALB homepage, http://meduni09.edis.at/eucalb/] 
 
 
3.2.3. Geographical distribution and activity 
 
I. ricinus is the most frequent tick species in Central Europe [184]. Their distribution stretches 
from Portugal to the Caspian Sea and Southern Scandinavia to North Africa (Fig. 11). In these 
regions I. ricinus can be found in heights of 0 – 2000 m above sea level [184, 188]. The 
limitation of the geographical distribution of Ixodes ticks lie mainly within the climatic factors 
[181]. As habitat ticks are using the vegetation near the ground at transitions of meadows to 
dense undergrowth, wood glades, forest paths and runways as well as open areas without tree 
population [188, 189]. 
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Fig. 10 Tick distribution [EUCALB homepage, http://meduni09.edis.at/eucalb/] 
 
To analyse and predict the occurrence of ticks and tick-borne-diseases in a spatial location 
GIS (geographical information system) is used. It’s a system of computer software, hardware 
and data and personal to manipulate analyse and present information [175]. 
 
The tick host-seeking activity is between March and October with different heights depending 
on their habitats and developmental stage. If there are really hot days the activity has its 
heights in the early morning, in the evening and at night. Ticks are located on exposed 
locations just under the top of the vegetation [178, 181]. The height depends on the 
developmental stage of the tick and consequently the size of the preferred host animal [188, 
189]. 
 
 
3.2.4. Host finding, attack and sucking action 
 
Larvae are located on grasses in up to 30 cm height, nymphs in about 100 cm height and 
adults can be found in heights up to 150 cm. All developmental stages have highly developed 
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sensory organs for the host finding. Through the hallers organ, paired sensory pits on the 
tarsus (foot) of the first pair of legs equipped with sensory hairs, the ticks can detect 
vibrations, scents and temperature. Light stimuli are detected through visual sensillia and 
chemical sensillia can detect tissue fluids. Furthermore ticks can detect heightened CO2 and 
ammonia concentrations as well as pheromones and kairomones (interspecies information-
bearing compound or mixture). After the host contact the tick needs only seconds for the 
adherence. Preferred for the blood sucking are humid, warm and well supplied with blood 
areas. In humans that are areas like thin skin parts, scalp, ears, throat, crook of the arm, knee 
bend, inguinal region as well as hands and feet. After the contact it takes before the blood 
sucking action starts. Than it takes 2 to 15 days till the tick finishes the sucking action [175, 
181, 184, 189, 190, 191, 192, 193]. 
For the sucking action the ticks use their stingingly sucking mandibles and they harden their 
selves in the host skin with the hypostome. A further fixation is provided by the cement-like 
saliva. Furthermore the saliva has an anaesthetic virtue so that the tick bite remains unnoticed. 
The feeding period of female ixodid ticks can be divided into three phases: (1) the 
preparatory feeding phase occupies the first day, when the female tick anchors itself in 
place, (2) the slow feeding phase occurs over the subsequent 4-8 days, when the female mates 
and increases its weight approximately 10-fold, (3) the rapid feeding phase occupies only 
about 24 hours, during which the female increases its weight a further 10-fold and then 
detaches from the host [175, 178]. 
As pool feeders ixodid ticks create an interior wound cavity which contains blood, digested 
vessel walls, dissolved cells and tissue liquid. During the blood meal the blood is immediately 
condensed to maximise the substance absorption. The so resulting water is transported back 
into the host through specialised salivary gland cells. During the whole blood meal there is a 
constant saliva secretion into the host to sustain and improve the anchoring and because of the 
immunosuppressive, anti-haemostatic, anti-inflammatory and analgesic properties of the tick 
saliva. Because the tick intestine lacks digestive enzymes several potential pathogenic 
microorganisms are transmitted to the host [175, 178, 194]. That could be one reason why 
particularly ticks transmit a greater variety of pathogens than other arthropod groups [190]. 
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3.2.5. Epidemiology 
 
In Europe it is assumed that more than 95% of all tick-borne diseases are associated with I. 
ricinus and I. persulcatus. Important pathogens transmitted by tick vectors are species of 
Anaplasma, Babesia, Borrelia, Erlichia, and Rickettsia species and the FSME virus [175, 189, 
193, 195]. In the case of Bartonella there have been publications which imply that ticks could 
play a role as vectors. Till now it remains premature to conclude that ticks might transmit 
Bartonellae to humans, but it is also premature to conclude otherwise [175, 196 – 203].
Relevant for the epidemiology of the Ixodes transmitted pathogens are the wide host 
spectrum, the reservoir function of hosts and ticks, the extent of tick infestation and the 
transfer mechanisms within tick populations [193]. Further importance lies on the capability 
of ticks to transmit pathogens transstadially and / or transovarially as well as the rare 
occurrence of passive transmission of bacteria through feeding in close proximity to other 
ticks (cofeeding) [184, 193, 204]. Moreover ticks have endosymbionts, like some Rickettsia 
and Wolbachia species, that indeed are transmitted transovarially and transstadially but after 
the current knowledge are non pathogenic [205]. So we are only talking about tick vectors if 
the carried microorganisms are transmitted “inoculative” to the host during the sucking action 
through continuous saliva secretion and occasional regurgitation of the intestinal contents 
[181]. 
 
 
3.3. Aims 
 
Over time many species of Bartonella have been affecting human life. This can be traced 
back till the time of the Inca Empire. It has even been implied that Bartonella quintana could 
have been one possible cause of the decline of the Inca Empire [2, 206]. 
Up to the present day, and especially the last 20 years, many new species have been 
discovered and known ones showed knew abilities. So the number of known Bartonella 
species is rapidly growing. Some of them are responsible for distinct infectious diseases and 
show different prevalence and antibiotic susceptibility profiles. Not only have some vectors of 
Bartonella been fully characterized, but also intermediate hosts are actually much more 
numerous and diverse than previously thought. Furthermore there is only a limited arsenal of 
antibiotics effective in vivo on this peculiar intracellular pathogen. This facts show the 
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importance of a focused Bartonella research, especially in the case of more effective 
molecular methods [207, 208]. As mentioned earlier it is also unclear if ticks transmit 
Bartonellae to humans, but it would be also premature to conclude otherwise [203]. 
In this study 4 strains of Bartonella (B. clarridgeiae, B. grahamii, B. henselae, and B. 
doshiae) were cultivated and used as positive controls for the design of Bartonella specific 
PCRs. With these Bartonella PCRs a tick library has been screened. The second part of the 
study involves the screening of two libraries of human sera for antibodies to Bartonella by an 
immunofluorescence test. 
 
 
3.3.1. Bartonella PCRs 
 
Two different PCRs were established: a Bartonella specific one and one for species 
differentiation. Therefor two target sequences were chosen: the 16S rRNA gene and the 16-
23S intergenic spacer region, whereas the primers for the ITS region were used for species 
differentiation. 
Furthermore the aim was to compare two different PCR detection methods for Bartonella 
species. The comparison was made for a Nested / Seminested PCR and a Real Time PCR. The 
following screening was performed with a tick library consisting of 10.326 Ixodes ricinus 
ticks (adult, nymphs and larvae) collected at different locations in Austria. 
 
 
3.3.2. IIF - Test 
 
An indirect immune fluorescence test was used in order to detect IgG antibodies against B. 
henselae and B. Quintana, and was performed for two libraries. The first library consisted of 
891 hunter sera (high risk group) of the year 2002. The second library was the reference group 
and consisted of 624 sera from blood donors of the year 2006. 
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4. Material and Methods 
 
4.1. Biological material 
 
4.1.1. Tick samples 
 
From spring up to summer 2005 ticks from several locations in every province of Austria 
have been collected (Fig. 12). The collecting was performed with the flagging method. For 
this a white cotton blanket was dragged over the vegetation. The ticks attached to the blanket 
where collected with forceps, arranged according to the developmental stage and frozen at -
20°C. 
This collection consists of 10.433 ticks (Tab. 4). 
 
Tab. 4 Tick collection 
 
For the screening only the Ixodes ricinus ticks were used and as a further differentiation the 
adult ticks were subdivided in male and female. 
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Fig. 12 Tick sampling sites 
 
 
4.1.2. Bartonella strains 
 
Four Bartonella species were obtained from the “Institute of Medical Microbiology of the 
Albert-Ludwigs-University Freiburg”. These strains of B. clarridgeiae, B. grahamii, B. 
henselae, and B. doshiae were used as positive controls for the PCR assays. B. doshiae was 
the only species which is not a human pathogen (Tab. 5). 
 
 
Tab. 5 Bartonella species 
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4.1.3. Human serum samples 
 
Serum samples were obtained from the serum collection of the Hygiene Institute. As a high 
risk group a hunter serum library of the year 2002 was used. Sera were then collected in 
collaboration with the “Burgenländischer Jagdverband”. 
As a reference to this high risk group a second library of red cross blood donors of the year 
2006 was used, kindly provided by the Austrian Red Cross. 
 
 
Tab. 6 Serum Libraries 
 
 
4.2. Solutions, reagents and Kits 
 
Tick DNA extraction from ticks: 70% and 100% ethanol (Merck) 
 DNeasy Tissue Kit (Qiagen) 
 Proteinase K (Roche Molecular Biochemicals) 
Isolation of DNA from bacteria: DNeasy Mini Kit (Qiagen) 
Primer and Probes: p24 E and E2 with TaqMan Hydrolysis probe p24; N-p24 
E and E2; 321s and as; BTNi F and R; Barton 1 and 2 
PCRs: 10x Reaction buffer B (Solis Biodyne) 
 dATP, dCTP, dGTP and dTTP (Solis Biodyne) 
 Hot Fire Polymerase (Solis Biodyne) 
 MgCl2 (Solis Biodyne) 
 SensiMix (Quantace) 
Agarose gel electrophoresis: 10x Loading buffer (Eppendorf) 
 50x TAE (Tris Acetat EDTA) 
 Agarose (Biozym) 
 Ethidium Bromide 
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 Step ladder (Sigma Aldrich) 
Gel-DNA Purification: GFX PCR DNA and Gel Band Purification Kit 
(Amersham Bioscience – GE Healthcare) 
PCR and Sequencing: 1x EDTA (Ethylenediaminetetraacetic) 
 70% and 100% ethanol 
 AB Mix – Big Dye Terminator v 1.1 cycle Sequencing RR 
– 100 Kit (Applied Biosystems) 
 Hidi Formamide 
IIF-Test: Bartonella henselae and Bartonella quintana IgG Biochip 
Kit (EUROIMMUN – Medical Labour Diagnostics) 
 
 
4.3. Culture medium 
 
Columbia agar + 5% sheep blood (BioMerieux – Clinical Diagnostics) 
for deep freezing: Roti – Store cryo-vials (Carl Roth GmbH + Co. KG) 
 
 
4.4. Methods 
 
4.4.1. Tick DNA extraction 
 
Every tick was separately incubated in 70% EtOH for at least 10 min and after that dried on a 
stage. Adults and nymphs were sliced with a sterile lancet and transferred into an Eppendorf 
tube (Eppi). Larvae were not sliced. So prepared the ticks were used for the DNA extraction 
with the DNeasy Tissue Kit. 
 
For the lysis 90µl of buffer ATL and 10µl of proteinase K (used the proteinase K of Roche 
Molecular Biochemicals and not the one provided from the kit; 14.4µg/µl water). The mixture 
was vortexed and incubated in a water quench at 60°C over night. The next step was the 
binding process. Therefor 100µl of buffer AL was added, followed by short vortexing and 
incubation at 70°C for 10 min. Than 100µl 96-100% EtOH were added, vortexed and spun for 
5 min. at maximum speed (e.g. 14.000rpm). The supernatant was pipetted (about 300 µl) and 
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applied to a DNeasy column with a collection tube. The column was centrifuged at 8.000rpm 
for 2 min. and the collection tube was discarded. For the washing step a new collection tube 
was used with the column. 500µl buffer AW1 were added followed by centrifugation at 
8.000rpm for 1 min. The collection tube was discarded again, the column was placed in a new 
collection tube and 500µl buffer AW2 were added. Centrifugation at 13.000rpm for 3 min. 
and the solution was discarded. This washing step with buffer AW2 was repeated and 
afterwards the column was spun for 3 min. at 13.000rpm to dry it. In the elution step the 
column was placed in an Eppi and 40µl, preheated to 67.5°C, AE buffer were added. The 
column was incubated for 5 min. at room temperature and afterwards spun 2 min. at 
8.000rpm. The eluate was aliquoted and stored at -20°C. 
 
 
4.4.2. Cultivation and Isolation of genomic DNA from Bartonella 
 
4.4.2.1. Bartonella cultivation 
 
The Bartonella strains were streaked onto blood agar plates with the streak plate procedure. 
An inoculation loop was sterilized through a Bunsen burner flame. With the cold sterilized 
loop a small amount of the bacterial growth was picked and immediately and gently streaked 
over a quarter of the agar plate (Fig. 13 area 1). The loop was flamed again and allowed to 
cool. Of the edge of area 1 which was just streaked, the streaks were extended into the second 
quarter of the plate (Fig. 13 area 2). The last step was repeated and the third dilution streak on 
the plate was produced (Fig. 13 area 3). Finally one further streak into the center of the plate 
was made (Fig. 13 area 4). 
 
 
 
 
 
 
 
 
  
 
 
Page  38 
 
  
 
Fig. 13 Streak plate procedure 
 
The inoculated streak plates were incubated at 37°C and a CO2 concentration of 5%. The 
incubation time depends on the Bartonella species and lies between 3 and 12 days. 
 
For deep freezing the grown and harvested Bartonella cultures were resuspended in cryo-
medium and should at least have a measured OD660 of 2. The suspension was filled into a Roti 
– Store cryo-vial and stored at -80°C. 
 
 
4.4.2.2. Isolation of genomic DNA from Bartonella 
 
The bacteria were harvested from a culture plate with an inoculation loop. Only one colony 
should be picked and the spot position marked on the plate. The isolation was performed 
according to the DNeasy Mini Kit of Qiagen. 
The harvested bacteria colony was suspended in 180µl of buffer ATL by vigorous stirring. 
20µl proteinase K were added, vortexed for 15 sec. and incubated at 56°C for 3 hours on a 
rocking platform. Afterwards the Eppi was centrifuged at 3.000rpm for 1 min. 200µl buffer 
AL were added, the mixture vortexed 15 sec., incubated at 70°C for 10 min. and again briefly 
centrifuged at 3.000rpm for 1 min. In the next step 200µl 96-100% EtOH were added, 
vortexed 15 sec. and again briefly centrifuged at 3.000rpm for 1 min. The whole mixture was 
applied to a spin column with a 2 ml collection tube and spun at 8.000rpm for 2 min. The 
collection tube with the flow-through was discarded and the spin column was placed in a new 
tube. 500µl of buffer AW1 were added and spun at 8.000rpm for 2 min. Once again the tube 
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with the flow-through was discarded. To the spin column with a new collection tube 500µl of 
buffer AW2 were added, centrifuged at full speed (e.g. 14.000rpm) for 3 min. and the tube 
with the flow-through was again discarded. The spin column with a new collection tube was 
centrifuged again at 14.000rpm for 1 min. The now dried spin column was placed in a clean 
Eppi and 200µl buffer AE was added. The incubation takes place at room temperature for 5 
min followed by the centrifugation at 8.000rpm for 1 min. The eluate was aliquoted in 1.5µl 
Eppis and stored at -20°C. 
 
 
4.4.3. Primer and Probes 
 
4.4.3.1. Primer 
 
The primer length and sequence are of critical importance in designing the parameters of a 
successful amplification. It should be complex enough so that the likelihood of annealing to 
sequences other than the chosen target is very low. The chance of finding an A, G, C or T in 
any given DNA sequence is ¼, for every dinucleotide 1/16 and for every further nucleotide 
growing exponentially. So, a sixteen base sequence will statistically be present only once in 
every 4 billion bases: this is about the size of the human or maize genome, and 1000x greater 
than the genome size of E. coli. Thus, the association of a greater-than-17-base 
oligonucleotide with its target sequence is an extremely sequence-specific process. 
Consequently, 17-mer or longer primers are routinely used for amplification from genomic 
DNA of animals and plants [211]. 
The melting temperature (Tm) of a nucleic acid duplex increases both with its length and with 
increasing G + C content. 
 
A simple formula to calculate the Tm is “The Wallace Rule”: 
Tm = 4(G + C) + 2(A + T)°C. 
 
Thus, the annealing temperature (Ta) chosen for a PCR depends directly on the length and 
composition of the primers. The Ta should be about 5°C below the lowest Tm of the primer 
pair to be used [209]. But there is also a more rigorous treatment of Ta [210]: they maintain 
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that if the Ta is increased by 1°C every other cycle, specificity of amplification and yield of 
the products <1kb in length are both increased. 
 
So important rules that have to be incorporated are [210]: 
 
 1. The primers should be between 17 and 20 bases in length 
 2. Base composition should be 50 to 60 % of G + C 
 3. Primers should have a G or C, or a GC or CG on the 3’ end to prevent “breathing” 
of the ends and so increase the efficiency of priming 
 4. Tm should be between 55 and 80°C 
 5. Runs of more than three Cs or Gs at the 3’ end should be avoided because of the 
risk of mispriming at G or C rich sequences on the target strand 
 6. The 3’ ends of the primers shouldn’t be complementary cause of the formation of 
primer dimmers 
 7. Primer self-complementarity should be avoided to prevent the formation of 
secondary structures like hairpins 
 8. Run a computer search against the vector and insert DNA sequences to verify that 
the primers are unique. 
 
 
4.4.3.1.1. Step by step procedure 
 
Through all steps of the primer creation the 8 rules should be incorporated as well as in any 
way possible. 
 
● The target sequence was chosen and download for every species to the program Clustal X 
1.83 and a database was compiled. The sequences were aligned and swept for suitable 
areas for the primers. If the primer set should just detect the genus in this case Bartonella 
the amplicon sequence between the primer pairs can be complementary between the 
species. On the contrary for species differentiation the amplicon sequence has to be 
diverged. 
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● In the next step a second database was compiled with all close related genera of Bartonella 
and with all possible genera that could contaminate the PCR. This database was aligned 
with the primer sets. So false positive results of the PCR assays could have been prevented. 
● The so found primer sets were specific for the genera, Bartonella, and were crosschecked 
with the NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). With the “BLAST” tool, 
especially the nucleotide blast, the specificity of the primers were determined. 
● Next was the control of the primer length and sequence. Therefor many free online tools 
were available, like “http://eu.idtdna.com/analyzer/Applications/OligoAnalyzer/”. This 
tool checks the primer length, GC content, Tm (even Tm settings when needed), hairpin 
structures, self-dimers and hetero-dimers. A good tool to control the folding of the 
sequences is mfold, “http://mfold.bioinfo.rpi.edu/” of Prof. Michael Zuker. 
● Finally the found primer sets were ordered at MWG (http://www.mwg-biotech.com/). 
 
 
4.4.3.2. Probes 
 
The TaqMan hydrolyses probe is a linear probe. The nucleotide acid sequence used for the 
probe is designed to bind between “sense” and “antisense” primer, so in the amplicon area. To 
produce a TaqMan probe several parts are needed. As already mentioned a specific nucleotide 
acid sequence with a length of 20 to 30bp. The length shouldn’t drop below 20bp to avoid 
unspecific hybridisation and shouldn’t exceed 30bp to avoid building of secondary structures. 
The guidelines for the sequence are much the same like for primers but there are some more 
points to be incorporated. Guanine bases on the 5’ end of the sequence should be avoided 
because even after the hydrolysis of the reporter (fluorophore) the guanine has the ability to 
quench the signal (Fig. 14). One difference to the primer design is that the GC concentration 
should be between 20 and 80%. To provide a higher stability for the probe sequence – 
template – hybrid the Tm of the probe should be 5 to 10°C higher than the one of the primers. 
The optimal binding site of the 5’ end of the probe is close to the 3’ end of the template. 
Further the strand should be selected that gives the probe more Cs than Gs. 
If the sequence complies the requirements a quencher can be attached at the 3’ end. The most 
common quencher dye is TAMRA (6-carboxy-tetramethyl-rhodamin) with an emission 
wavelength of 580nm. The quencher is attached to the 3’ end of the probe through a linker 
arm nucleotide (LAN). The 3’ OH of the probe is blocked through a special phosphate. 
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Finally a reporter dye has to be attached covalently to the 5’ end of the probe. The most 
common dye is FAM (6-carbox-fluorescein) with an emission wavelength of 518nm (Fig. 15) 
[212]. If the reporter dye and the quencher dye are in close proximity (10 to 100Å) the 
fluorescence-resonance-energy-transfer (FRET) occurs. That means a distance-dependent 
interaction between the electronic excited states of two dye molecules in which excitation is 
transferred from a donor molecule to an acceptor molecule without emission of a photon 
(quenching) [213]. The so excited acceptor (quencher dye) emits the received energy in its 
specific wavelength which is different to the one of the reporter dyes. During the PCR the 
single stranded parts of the probe are hydrolysed through the Taq polymerase. So the spatial 
distance between the reporter and the quencher dye increases and thus FRET does not occur 
(Fig. 14). 
 
 
Fig. 14 Function principle of a TaqMan probe 
 
 
 
 
 
  
 
 
Page  43 
 
  
 
Fig. 15 Chemical structure of a TaqMan probe [212] 
 
 
4.4.4. PCRs 
 
4.4.4.1. PCR, Semi-nested PCR and Nested PCR 
 
This molecular biological technique was founded by Kary Mullis in 1983. It is based on the 
denaturation of a double-stranded DNA (Fig. 16 - 1 denaturation), to which at the 5’- and 3’- 
end of the specific area to amplify oligonucleotide molecules bind (Fig. 16 – 2 annealing). 
The oligonucleotides will be elongated through a DNA-dependent DNA-polymerase, in the 
presence of free desoxynucleoside-triphosphate (dNTP) (Fig. 16 -3 elongation). The DNA-
polymerase elongates the DNA double-strand till such time as it drops down the DNA or the 
reaction is interrupted. This interruption occurs when the incubation-temperature is raised to 
95°C and is combined with the repeat of the denaturation. If the reaction mixture is cooled 
down to 40-60°C free oligonucleotides bind, dependent of their Tm values, to their 
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complementary DNA-matrix sequences. With this method the target sequence can be 
replicated exponentially [214]. 
 
 
Fig. 16 Schematic PCR cycle 
 
For the standard PCR one primer set is needed. A “forward” and a “reverse” primer with the 
binding site in between the target sequence. 
In contrary the Semi-nested and Nested PCR consist of two succeeding amplifications. The 
first is the same like in the standard PCR with primers outside the wanted PCR-fragment. The 
second one, in the case of a Semi-nested PCR, uses one primer of the first amplification and 
for the second one a new primer in between the amplicon sequence of the first amplification. 
The second amplification for the Nested PCR is pretty much the same like the Semi-nested 
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one. The only difference is that both primers are in between the amplicon sequence of the first 
amplification. So in the second amplification the amplicons of the first one are used with the 
result of higher product specificity through the minimization of unspecific side-products 
[214]. 
 
The reaction mixture for a PCR consists of dH2O, the reaction buffer, MgCl2, the primer set, 
dNTPs, the polymerase (Hot fire polymerase) and the target DNA. 
The reaction buffer supplies the polymerase with all needed chemical components. So it 
provides an approximative optimal milieu for the enzyme at different temperature levels. The 
buffer consists of Tris-HCl, (NH4)2SO4 and Tween-20. 
Magnesium chloride is a metabolic cofactor for most DNA polymerases. The Mg
2+
 ions 
influence the enzyme activity, raise the dsDNA melting temperature and form a soluble 
complex with nucleotides, in what way the substrate is formed which is recognised by the 
polymerase. So the MgCl2 concentration can influence the specificity and yield of the PCR. 
The standard concentration lies between 1.0 and 2.5 mM. 
The dNTPs are the substrates for the DNA polymerase. The quality of the dNTPs lies in the 
content of base-modifications. The lower the content of modified bases the higher is the 
quality of the dNTPs for a PCR. 
The Hot-start polymerases are modified versions of a normal polymerase with the advantage 
to be thermostable and are only activated by a 15 min. incubation step at 95°C. So during the 
preparation of the reaction mixture no unwanted amplification occurs [214]. 
 
 
4.4.4.1.1. Standard PCR Step by step procedure 
 
The standard PCR was performed with 6 different primer sets: p24 E and p24 E2, BTNi F and 
BTNi R, Bart 2 and Bart 1R, 321 s and 321 as and Barton 1 and Barton 2. As already 
mentioned (see 4.4.3.1 Primers) the primers have been designed and constructed in 
accordance to the general rules of primer design [210, 214]. To adjust the PCR for Bartonella 
detection several runs were performed with positive controls of different Bartonella species 
with different concentrations. Through dilution series the proper concentration of the positive 
controls could have been found. For a normal run two standards were needed as controls: one 
Master-mix with the positive control and one with dH2O as negative control. 
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So the first step was to pipet the Master-mix (Tab. 7). First the dH2O was pipette, then the 
reaction buffer and the MgCL2, next were the primers and the dNTPs and finally the 
polymerase. This Master-mix was used for all PCR-samples. The Master-mix was pipette to 
500µl Eppis and combined with the different DNA templates which were tested and the 
different controls. The whole pipetting-procedure was performed on ice to prevent unwanted 
reactions before the PCR run has started. Because of this reason it was important to adhere to 
the pipetting order as described above. 
 
 
Tab. 7 Standard PCR Reaction Mixture 
 
After the pipetting step the prepared Eppis were loaded to the PCR cycler. A program with the 
proper time and temperature steps was set (Tab. 8). The proper Ta’s were determined through 
a temperature-gradient PCR. 
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Tab. 8 Cycler Program Standard PCR 
 
 
4.4.4.1.2. Nested / Semi-Nested PCR Step by step procedure 
 
The nested and semi-nested PCR is very much the same like the standard PCR. The first PCR 
run was performed with the external primer set p24 E and p24 E2 and the template DNA 
(Tab. 9). 
 
 
Tab. 9 Cycler Program Nested / Semi-Nested PCR 
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The second run was performed with the amplicons of the first run and the internal primer set 
N-p24 E and N-p24 E2 in the case of the nested PCR and p24 E and N-p24 E2 in the case of 
the semi-nested PCR (see also 4.4.4.1 PCR, Semi-nested PCR and Nested PCR). The 
difference in the reaction mixture was that in the step II PCR the amplified sequences of the 
first run were used (Tab. 19). 
 
 
Tab. 10 Reaction Mixture Nested / Semi-Nested PCR 
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4.4.4.2. Real-Time PCR 
 
The main advantage to the standard-PCR is that the Real-Time PCR can measure the 
amplified matrixes directly (in real time). So this feature coins the name Real-Time-PCR 
[215]. For the detection of the amplicon amount fluorescent molecules (fluorophores) are 
used. This molecules are bound to the sequence specific oligonucleotides (see chapter 4.4.3.2 
Probes). The principle of the detection relies on the extinction of the used fluorophore through 
short-wave light and the emission of longer-wave light (between 500 and 800nm). This 
emission is detected by an optical detection-unit per PCR cycle and in addition the 
fluorescence-intensity is measured [214]. 
 
The reaction mixture for a Real-time PCR is similar to the one of the standard PCR: dH2O, 
reaction buffer, MgCl2, the primer set, dNTPs, the polymerase and the target DNA. Only one 
further thing has to be added if not working with SYBR green as fluorophore, the probe 
sequence. 
 
 
4.4.4.2.1. Step by step procedure 
 
Like the standard PCR the reaction mixture was pipette on ice. In addition the handling with 
the probe was performed fast to prevent long light exposure because the fluorophore of the 
probe is photosensitive. The probe final concentration should be about one third of the primer 
concentration (Tab. 11). The standards should be used in triplicates if possible. The cycler 
program differed from the normal PCR as can be seen in Tab. 12.  
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Tab. 11 Reaction Mixture Real-Time PCR 
 
 
Tab. 12 Cycler Program Real-Time PCR 
 
 
4.4.5. Agarose gel electrophoresis 
 
The 50x TAE stock solution was diluted with dH2O to a 1x TAE solution. TAE has the 
function as electrophoretic running buffer. If the buffer concentration is too low, to less ions 
are available for the electric conductivity and the migration velocity of the DNA is very low. 
On the other hand side if the buffer concentration is too high, the good electric conductivity 
results in a heat generation which denaturants the DNA and melts the gel. So it’s important to 
have a proper concentration of the running buffer. For a 3% small gel 100ml 1x TAE and 3g 
Agarose were mixed and shortly boiled up. During the cooling process down to room 
temperature the mixture was stirred continuously. At RT 5µl vortexed ethidium bromide was 
pipetted to the mixture and all together poured into the small gel rack. Then the comb was 
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inserted to produce the needed wells for the loading of the PCR products. Till the gel was 
cooled down and had become solid it was stored in a cold and light protected surrounding. 
The next step was to carefully remove the comb and put the gel with the rack into the 1x TAE 
filled tank. The wells were located on the side of the electrode that had the negative current. 
Because the ethidium bromide is very UV sensitive the gel was protected from light exposure 
as good as possible. 
After the PCR run 27µl of the PCR product was pipetted in a new Eppi filled with 3µl of the 
10x loading buffer consisting of Bromophenol Blue, Xylene Cyanol FF, EDTA, pH 8.0 and 
50% Glycerol in dH2O. This DNA gel loading buffer is intended to facilitate loading of the 
samples into the wells. It increases the density of the sample and gives it a colour, thus 
facilitating the loading procedure. In addition, the two dyes migrate in the same direction as 
the nucleic acids, serving as rough indicators of the electrophoretic progress. When the gel 
loading buffer was added to mixtures containing enzymes that require Mg
2+
 or Ca
2+
 for their 
reactivity, the EDTA in the buffer terminated these reactions. 
One Eppi was prepared with a proper step ladder, depending on the fragment length of the 
amplicon sequences, to determine the size of the bands after the gel run. It was an 
electrophoresis marker for DNA containing 17 bands ranging from 50bp to 3000bp. 90µl step 
ladder and 10µl 10x loading buffer were mixed and 20µl were injected into the first well. If 
possible there should be one empty well between the controls and the samples to prevent false 
results through flowing of the mixtures into one another. After the loading process the power 
supply was turned to 75V with a run time counter of 60 to 65 minutes. 
The analysis of the gel was performed with a gel-documentation equipment. The ethidium 
bromide, intercalated in the DNA, was exposed to UV-light resulting in a fluorescence cause 
of the phenanthridine moiety. The ethidium bromide in the gel was fluorescing too but 
through the intercalation and in further consequence the conformational change of the 
ethidium bromide the fluorescence of the intercalated agent was intensified almost 20 fold. So 
a photograph of the gel was taken under ultraviolet lighting conditions. 
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4.4.6. Gel-DNA Purification 
 
Before the bands of interest in the agarose gel were used for sequencing they had to be 
purified. Therefor the “GFX PCR DNA and Gel Band Purification Kit” was used. The bands 
were cut out of the gel with a maximum weight of 900mg. For each 10mg gel slice 10µl 
capture buffer type 3 were added. The type 3 buffer contains a pH indicator that changes 
colour at various pH levels to identify whether the capture buffer plus sample mix is at the 
optimal pH for DNA to bind to the silica membrane. Than the Eppi was mixed by inversion 
and incubated at 60°C for 15-30 min. until the agarose was completely dissolved. Once the 
agarose was completely dissolved the capture buffer type 3-sample mix had to be yellow or 
pale orange in colour. If the colour differs a small volume of sodium acetate had to be added 
till the colour fits the requirements. After that, for every purification, a GFX MicroSpin 
column was placed into one collection tube. Up to 800µl of the capture buffer type 3-sample 
mix was transferred onto the assembled GFX MicroSpin column with the collection tube. It 
followed an incubation at RT for 1 min and a spinning at 16.000 x g for 30 sec. The flow 
through was then discarded and the GFX MicroSpin column with the empty collection tube 
was used for the washing and drying step. 500µl wash buffer type 1 were added to the GFX 
MicroSpin column to remove salts and other contaminations from the membrane bound DNA. 
The column with the collection tube was spun at 16.000 x g for 30 sec and then the collection 
tube with the flow through was discarded. The column was placed to a normal 1.5ml Eppi for 
the elution step. For the elution buffer type 6, sterile nuclease free water, was used. 40µl were 
added to the center of the membrane of the MicroSpin column and incubated at RT for 1 min. 
After that the column with the Eppi was spun at 16.000 x g for 1 min. to recover the purified, 
membrane bound DNA. The eluate was used for sequencing and could have been stored at -
20°C for a short-time. 
 
 
4.4.7. Sequencing PCR and Sequencing 
 
The purified PCR product was used for a sequencing PCR. Therefor the AB-Mix was mixed 
with the PCR product, a forward or reverse primer and dH2O (Tab. 13). The AB-Mix 
consisted of MgCl2, reaction buffer, dNTPs and polymerase. Only one primer was needed 
because the classical chain-termination method after Sanger requires a single-stranded DNA 
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template [218]. The PCR product concentration in the reaction mixture depends on the length 
of the amplicon sequence. Between 100 and 200bp 1 to 3ng are needed, from 200 to 500bp 3 
to 10ng are needed and between 500 and 1000bp 5 to 20ng have to be used. The mixture with 
a reaction volume of 10µl was stirred gently and centrifuged briefly at 3.000 rpm for 1 min. 
For the sequencing PCR a special cycler program was used (Tab. 14). 
 
 
 
Tab. 13 Sequencing PCR reaction mixture 
 
 
 
Tab. 14 Cycler program sequencing PCR 
 
 
After the sequencing PCR the product was purified. Therefor the PCR Eppis with the product 
were centrifuged briefly at 3.000 rpm for 1 min. The 10µl of the reaction mixtures were 
pipetted to a 500µl Eppi containing 1µl vortexed NaOAc buffer. Then 33µl 100% EtOH were 
added and the mixture vortexed briefly and incubated on ice for 20 min. It followed a 
centrifugation step for 30 min. at 4°C and maximum speed. The supernatant was discarded, 
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90µl of 70% EtOH were added and centrifuged for 10 min. at 4°C and maximum speed. The 
supernatant was discarded and the sample dried at RT for 5 min. In this time the HiDi 
formamide was thawed and the thermo-mixer with dH2O filled Eppis preheated to 95°C. 20µl 
of the thawed and vortexed HiDi formamide was pipetted to the sample and incubated at RT 
for 5 min. The HiDi formamide is a hygroscopic dissolvent and reductant with the purpose of 
stabilizing and denaturing of nucleic acids and so preventing the formation of hairpin 
structures. The next incubation step was in the prepared thermo-mixer water quench at 95°C 
for 5 min. Finally the sample was centrifuged briefly at 3.000 rpm for 1 min. and 
subsequently incubated on ice for at least 5 min. The so purified sample was used for the 
sequencing directly. 
After sequencing the sample nucleotide sequences was identified through the NCBI database 
“BLAST” tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
 
4.4.8. Indirect Immunofluorescence-Test 
 
The secondary or indirect immunofluorescence test uses two different antibodies. The first or 
primary antibodies against B. henselae or B. quintana recognise the target molecules which 
are B. henselae- and B. quintana- infected cells attached to the slides and bind to them. The 
second or secondary antibodies are fluorescein-labelled anti-human antibodies which bind to 
the primary antibodies and so staining them. The samples to be tested were diluted after the 
dilution series schema: 1:10, 1:32, 1:100, 1:320 and 1:1.000. For qualitative analysis the 
antibody titer of 1:320 was used as a reference [219]. 
 
 
4.4.8.1. Step by step procedure 
 
For a standardized immunological analysis the EUROIMMUN Titerplane technique was used. 
25µl of the diluted samples (see 4.4.8 Indirect Immunofluorescence-Test) were applied to the 
reaction fields of a reagent tray. The biochip-slides were then placed into the recesses of the 
reagent tray, where all BIOCHIPs of the slide come into contact with the fluids, and the 
individual reactions commence simultaneously. On every chip one negative and the positive 
controls for B. henselae- and B. quintana had to be added. The samples were incubated for 30 
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min. at RT. After the incubation follows the washing step where the biochip-slides were 
rinsed with a flush of PBS-Tween and afterwards were immersed immediately for at least 5 
min. in a cuvette containing PBS-Tween. In the next step 20µl of fluorescein-labelled anti–
human immunoglobulin was pipetted onto each reaction field of a cleaned reagent tray. Then 
one biochip-slide after another was removed from the PBS-Tween, blotted with a paper towel 
on the back and the long edges and immediately put into the recesses of the reagent tray. 
During the following incubation period of 30 min. at RT the slides had to be protected from 
direct light exposure. After the incubation follows the washing step where the biochip-slides 
were rinsed with a flush of PBS-Tween and afterwards were immersed immediately for at 
least 5 min. in a cuvette containing PBS-Tween. Also after the second incubation followed a 
washing step where the biochip-slides were rinsed with a flush of PBS-Tween and afterwards 
were immersed immediately for at least 5 min. in a cuvette containing PBS-Tween. After this 
step for every 150µl PBS-Tween 10 drops of Evans Blue were added for counterstaining. In 
the embedding step 10µl drops of glycerol per each reaction field were placed onto a cover 
glass. Then one biochip-slide after another was removed from the PBS-Tween, dried with a 
paper towel on the back and the edges as well as the surface around and put onto the prepared 
cover glasses. In the evaluation step the slides were analysed by using fluorescence 
microscopy. 
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5. Results 
 
5.1.1. Tick DNA extraction 
 
From the Austrian tick collection of 10.433 ticks (see Tab. 4), 24 ticks of every location have 
been picked for extraction. Each time 8 larvae, 8 nymphs and 8 adults whereas the adults 
consisted of 4 male and 4 female ticks (Tab. 15). The extraction resulted in eluates with 40µl 
AE buffer in each of them. They were aliquoted to two Eppis with 20µl and stored at -20°C. 
 
 
 
Tab. 15 Processed Ticks of Austria 
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5.1.2. Cultivation and Isolation of genomic DNA from Bartonella 
 
5.1.2.1. Bartonella cultivation 
 
As already mentioned four Bartonella species were used for cultivation and subsequently as 
positive controls for the PCR-assays (see Tab 5). The results of the cultivation showed that 
under equal conditions B. clarridgeiae needed a much longer start-up phase in comparison to 
the other species. Even after 7 days no colony could have been detected visually against what 
B. grahamii, B. henselae, and B. doshiae were close to their stationary phase. B. clarridgeiae 
showed the first visible colonies after 9 to 10 days (Fig. 17). 
 
 
 
Fig. 17 Bartonella Cultivation on Columbia Blood-Agar Plates 
 
 
5.1.2.2. Isolation of genomic DNA from Bartonella 
 
Of this cultivated culture plates single colonies have been picked and new subculture plates 
were produced in duplicates. Of one of these subcultures the whole plate is harvested and 
deep frozen at -80°C with Roti–Store cryo-vials. The second subculture is used to pick a 
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single colony to isolate the genomic DNA with the DNeasy Mini Kit of Qiagen (Tab. 16). It 
resulted in eluates with 200µl AE buffer aliquoted to 4 Eppis and stored at -20°C. 
 
 
Tab. 16 Bacterial cultures of Bartonella on Sheep-blood Agar Plates 
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5.1.2.3. Bartonella positive Controls 
 
The Bartonella positive controls were used for the PCR-assays. So it was essential to measure 
the concentration of the stock solutions and create dilution series (Tab. 17). The focus for the 
dilution series was to find dilution levels were the Bartonella positive controls with different 
stock solutions have the same concentration and were close to the detection limit of the PCR-
assay (Tab. 18). Through this dilution series the sensitivity of the PCR-assays could have 
been tested. The DNA concentration measurement was performed with a NanoDrop 
Spectrophotometer. Some data of the measurement had to be observed to be sure that the 
positive controls are suitable for the PCR’s. The ratio of sample absorbance at 260/280nm is 
used to assess the purity of DNA and RNA. A ratio of about 2 is generally accepted as pure. 
The ratio of 260/230 is a further measure of nucleic acid purity with an optimal range between 
1.8 and 2.2. At A260 is the absorbance of nucleic acids and at A280 the one of mainly 
proteins (Tab. 17). So the measurement curves should show a peak at 260nm and a lower 
value at 280nm (Fig. 18-21). 
Further information about the positive control dilution series and the PCR sensitivities are 
provided at chapter 5.1.4 PCRs. 
 
 
 
Tab. 17 Concentrations of the Bartonella positive controls measured with a NanoDrop Spectrophotometer 
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Tab. 18 Concentrations of the Bartonella positive controls with the dilution series 
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Fig. 18 Concentration measurement curve of the B. clarridgeiae positive stock solution 
 
 
Fig. 19 Concentration measurement curve of the B. doshiae positive stock solution 
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Fig. 20 Concentration measurement curve of the B. henselae positive stock solution 
 
 
Fig. 21 Concentration measurement curve of the B. quintana positive stock solution 
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5.1.3. Primer and Probes 
 
For the PCR-assay seven different primer sets have been found which fit the requirements and 
the rules (see chapter 4.4.3 Primer and Probes) for proper primer design (Tab. 19 and 20). In 
table 19 details of the location on the target sequence have been given. Therefore the 
sequences of the target gene of all Bartonella species have been aligned. Depending on these 
aligned sequences the locations of the primers were determined (Fig. 22-24). The same 
procedure was implemented for the Real-Time PCR probe. The second table (Tab. 20) shows 
the primer sets with their target sequences, the primer Tm values and the resulting mean Ta 
values and the measured optimal Ta values (see chapter 5.1.4 PCRs). This optimal Ta values 
have been determined through several PCR runs with a temperature gradient. 
 
 
 
Tab. 19 PCR Primers Table I 
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Tab. 20 PCR Primers Table II 
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Fig. 22 Section of the 16S rRNA gene with the p24 E and E2 primer binding sites marked with a red rectangle 
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Fig. 23 Section of the 16-23S ITS region with the 321s and as primer binding sites marked with a red rectangle 
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Fig. 24 Section of the ribC gene with the Barton 1 and 2 primer binding sites marked with a red rectangle 
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5.1.4. PCRs 
 
5.1.4.1. PCR, Semi-nested PCR and Nested PCR 
 
First step was to calibrate the PCRs. Therefor the primer sets were tested with a constant 
concentration of the positive control (Fig. 25). The gel shows the different amplicons of the 
primer sets. The differences in the intensity of the bands refer to the different dilution levels 
of the primers (Tab. 21). Through the marker the bands in lane 3 and 5 could have been 
estimated at 590bp, for lane 8, 9 and 11 at 220bp and the lanes 12, 13 and 14 at 430bp. So the 
results correspond with the expected sizes (see Tab. 19 PCR Primers Table I). Furthermore 
the results showed that the primers concentration has a lower limit at the dilution of 1:1000 
(Lanes 7, 11, 14). This dilution corresponds roughly to 10nM of the primer final concentration 
in the master-mix. The lanes 16 to 18 were used to test the primer set Bart 1R and 2. Even 
after several further PCR runs with this primer set no bands could have been produced. 
Therefor this primer set was discarded. 
 
 
 
Fig. 25 PCR gel with a constant positive control and different concentrations of the primers 
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Tab. 21 PCR gel mixture table 
 
 
The next step was to detect the proper Ta values. Therefor PCRs with a temperature gradient 
have been performed (Fig. 26 – 27 and Tab.22 - 23). In both gels one tested primer set was 
Bart 1R and 2 which, as already mentioned, showed no results. For p24 the optimal Ta value 
was at 56.4°C in lane 5. Lane 2 with 51.8°C was too far away of the mean Ta value and lane 3 
and 4 showed unspecific amplification at about 900bp. In the case of Barton the optimal Ta 
value was at lane 12 with 54.3°C. The best Ta value for BTNi was at lane 5 with 53.1°C and 
for 321 at lane 14 with 56.0°C. 
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Fig. 26 PCR gel with a constant positive control and different Ta values I 
 
 
Tab. 22 PCR gel mixture table referring to Fig. 26 
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Fig. 27 PCR gel with a constant positive control and different Ta values II 
 
 
Tab. 23 PCR gel mixture table referring to Fig. 27 
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The following PCRs were performed to test the detection limit. Therefor different 
concentrations of the positive controls were used (Fig. 28-30 and Tab. 24-26). As can be seen 
in the following gels the sensitivity limit of the PCR was detected at about 0.34pg/µl genomic 
DNA, lanes 4, 7, 10 and 13 in figure 30. 
 
 
Fig. 28 PCR gel with different concentrations of the positive control I 
 
 
Tab. 24 PCR gel mixture table referring to Fig. 28 
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Fig. 29 PCR gel with different concentrations of the positive control II 
 
 
Tab. 25 PCR gel mixture table referring to Fig. 29 
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Fig. 30 PCR gel with different concentrations of the positive control III 
 
 
Tab. 26 PCR gel mixture table referring to Fig. 30 
 
 
Finally the different primer sets were tested with dilution series of the different positive 
controls (Fig. 31 and Tab. 27). The results have been analysed and compared with the values 
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measured with Clustal X 1.83 (Tab. 28). Furthermore the band intensity has been verified 
through the results of the dilution series. In the end the best results have been achieved with 
the primer set p24 E&E2 so it was chosen for the screening of the tick library. 
 
 
Fig. 31 Final calibration PCR gel with all primer sets and different concentrations of the positive controls 
 
 
Tab. 27 PCR gel mixture table referring to Fig. 31 
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Tab. 28 Final PCR gel results compared with Clustal X values 
 
 
5.1.4.1.1. PCR Tick Screening 
 
The tick screening was performed with a Nested PCR due to fact that with the Standard PCR 
and the Semi-Nested PCR no positive ticks could have been detected. This result didn’t 
correlate with other studies. So it had to be assumed that the PCR was not sensitive enough to 
detect Bartonella DNA in ticks. Especially when these ticks have been frozen for several 
years and the DNA degraded over time. The alternative, to pool ticks was not used because of 
two main advantages of the Nested PCR. First through a Nested PCR higher product 
specificity as well as a minimization of unspecific side-products can be achieved. Especially 
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the minimization of the side-products is an advantage for the following sequencing procedure. 
The second reason is that every tick can be tested separately and so it’s much easier to 
differentiate between male and female adult ticks. 
 
In the first gel the ticks of the region Vienna have been screened (Fig. 32 and Tab. 29). In lane 
1 and 20 the step ladder was loaded as a length marker with a 400bp band marked with the red 
rectangle. The expected bands at 390-391bp show the amplicon of the nested primer set N-
p24 E and E2. So the tick samples in the lanes 4, 5, 6, 8, 11, 12, 13, 16, 17 and 19 could have 
been verified as Bartonella positives. 
 
 
 
Fig. 32 Nested PCR tick screening of the region Vienna – Prater / Lusthaus (Index 5) 
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Tab. 29 PCR gel mixture table referring to Fig. 32 
 
The following two gels show the final results of the tick screening taken together (Fig. 33-34 
and Tab. 30-31). All PCRs have been performed with the external primer set p24 E and p24 
E2 and the internal primer set N-p24 E and N-p24 E2. The bands, in the case that the tick 
sample is positive, should be at 390-391bp which represent the amplicon of the internal 
primer set on the Bartonella 16S rRNA gene. For a better visualization the 400bp bands of the 
step ladder has been marked with a red rectangle. 
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Fig. 33 Nested PCR tick screening final summarized results of all regions part I 
 
 
Tab. 30 PCR gel mixture table referring to Fig. 33 
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Fig. 34 Nested PCR tick screening final summarized results of all regions part II 
 
 
Tab. 31 PCR gel mixture table referring to Fig. 34 
 
So in the end 23 ticks out of 216 could have been tested positive for Bartonella (Fig. 35). This 
corresponds to a percentage of infection of 10.6%. Especially the results of Vienna showed a 
very high rate of infection with 41.7% (Tab. 32). There are several possibilities that could 
cause such a high rate of infection. Because of the close proximity to the city and a high tick 
density in the area several transmission methods are benefitted. First the transstadial and 
transovarial transmission of the pathogens can result in a higher rate of infection. Then there 
is the possibility, even if it has a rare occurrence, of passive transmission of bacteria through 
feeding in close proximity to other ticks (cofeeding) [184, 193, 204]. This could be a possible 
explanation of a rate of infection close to 50%. 
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Fig. 35 Nested PCR tick screening results diagrammed 
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Tab. 32 Regional distribution of the Bartonella positive ticks 
 
 
5.1.4.2. Real-Time PCR 
 
The first step was to test the Real-Time PCR with the primer set p24 E and E2 provided for it 
(Fig. 36-38 and Tab. 33). For the PCR standard curve at least 3 points are needed and every 
concentration should be run at least in duplicate. This results in a more accurate standard 
curve. The NCs provide a mechanism to control for external contamination or other factors 
that can result in a nonspecific increase in the fluorescence signal. Ideally, signal 
amplification should not be observed in the NC sample wells. If the NTCs do cross the 
threshold, their Cts should be at least five cycles, and preferably more than ten cycles, from 
the Cts of your least concentrated samples [220]. 
 
Furthermore a Dissociation (Melting) Curve Analysis was performed with SYBR Green. All 
products generated during the PCR amplification reaction are melted at 95°C, then annealed 
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at 55°C and subjected to gradual increases in temperature. During the incremental 
temperature increases, fluorescence data are collected until the reaction reaches 95°C. The 
result is a plot of raw fluorescence data units, R, versus temperature (Fig.38). As the 
temperature increases, the DNA melts and the fluorescence intensity decreases. The 
temperature at which a DNA molecule melts depends on its length and sequence; therefore, if 
the PCR products consist of molecules of homogeneous length and sequence, a single thermal 
transition will be detected. So even primer dimers or primer-probe binding can be detected 
[220]. 
 
 
 
Fig. 36 Real-Time PCR adjustment – Three positive controls in duplicate 
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Fig. 37 Real-Time PCR adjustment – Negative controls 
 
 
Fig. 38 Real-Time PCR adjustment – Dissociation Curve 
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Tab. 33 Real-Time PCR mixture table referring to Fig. 36-38 
 
 
The B. henselae spiked positive controls have been used in three different dilutions and in 
duplication (Fig. 36). The results of the Dissociation curve analysis showed only peaks at the 
same temperature level. This means that the PCR resulted in only one amplicon product and 
no primer dimers have been formed (Fig. 38). In the case of the NCs no fluorescence could 
have been detected (Fig. 37). 
 
The following plots show the final results of the tick screening with Real-Time PCR and the 
p24 E and E2 primer set (Fig. 39-45 and Tab. 34-40). The increased fluorescence after 48 to 
50 cycles is a result due to thermal, non-specific, degradation of the hydrolysis probe. So an 
increase of the fluorescence after these cycles shouldn’t be rated as a positive result. 
In plot 39 and 40 only the first positive control duplicate has been detected due to errors in the 
PCR Eppis which resulted in the vaporisation of the reaction mixture. But it had no further 
effects on the results of the plots. 
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Fig. 39 Real-Time PCR Screening Niederösterreich 
 
 
Tab. 34 Real-Time PCR mixture table referring to Fig. 39 
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Fig. 40 Real-Time PCR Screening Salzburg 
 
 
Tab. 35 Real-Time PCR mixture table referring to Fig. 40 
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Fig. 41 Real-Time PCR Screening Kärnten 
 
 
Tab. 36 Real-Time PCR mixture table referring to Fig. 41 
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Fig. 42 Real-Time PCR Screening Oberösterreich 
 
 
Tab. 37 Real-Time PCR mixture table referring to Fig. 42 
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Fig. 43 Real-Time PCR Screening Tirol and Vorarlberg 
 
 
Tab. 38 Real-Time PCR mixture table referring to Fig. 43 
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Fig. 44 Real-Time PCR Screening Burgenland and Steiermark 
 
 
Tab. 39 Real-Time PCR mixture table referring to Fig. 44 
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Fig. 45 Real-Time PCR Screening Wien 
 
 
Tab. 40 Real-Time PCR mixture table referring to Fig. 45 
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With the Real Time PCR screening of the tick samples 16 ticks out of 216 could have been 
tested positive for Bartonella (Fig. 46). This corresponds to a percentage of infection of 7.4%. 
The regional distribution of Bartonella positive ticks had its highest level in Vienna with 
33.3% (Tab. 41). 
 
 
 
Fig. 46 Real Time PCR tick screening results diagrammed 
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Tab. 41 Regional distribution of the Bartonella positive ticks 
 
 
5.1.4.3. Comparison of the Results Real Time and Nested PCR 
 
With both methods the same tick samples could have been detected as positives. However the 
Nested PCR resulted in 7 more positives (Fig. 47). This 7 positive samples had been tested a 
second time to verify these positive results. This raises the question why there was such a 
great difference between the two methods. I wouldn’t say that a Nested PCR in general is 
more sensitive than a Real Time PCR. Much more accurate is that the Real Time PCR could 
have been adjusted not optimally. This could result in the decrease of the sensitivity. 
As a disadvantage of the Real Time PCR has to be mentioned that the 16-23S Intergenic 
Spacer Region is not suitable to be used as a target sequence. The sequences between the 
primer binding sites are so differing among the Bartonella species that it is not possible to 
find a proper probe binding site (Fig. 23). So a species differentiation has to be performed 
with the Nested PCR. 
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Fig. 47 Comparison of the Real Time and Nested PCR tick screening results diagrammed 
 
 
5.1.4.4. PCR for species differentiation 
 
The PCR to differentiate between the Bartonella species was performed with the primer set 
321s and 321as. The target sequence was the 16-23S Intergenic Spacer Region. As already 
mentioned above this target sequence was not suitable for the Real Time PCR so the 
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differentiation was only performed with the Standard PCR method. As a matter of fact, during 
the diploma theses it was not possible to receive proper results cause of some unknown 
problems with the PCR gel results (Fig. 48). The primer design for the primer set 321 has 
been repeated and the primer test results had been good (see Chapter 5.1.4 PCRs). So there 
was no explanation for the multiple bands in the gel results. 
The gel in figure 48 shows one of these not interpretable results. In lane 1 and 19 the step 
ladder was loaded. Lane 6 shows the . grahamii spiked positive control at about 300bp 
which correlates with the Clustal X value of 307bp (see Tab. 28). In lane 18 was the negative 
control. Only lane 2 shows a proper result which points to B. grahamii or B. vinsonii sub 
berkhoffii. But because of the remaining unclear results the one in lane 2 couldn’t be assessed. 
Furthermore the sequencing of the amplicon in lane 2 didn’t lead to any result.
 
 
 
Fig. 48 Differentiation PCR result with primer set 321s and as 
 
 
5.1.5. Sequencing PCR and Sequencing 
 
The sequencing PCR was performed with the primer p24 E in the case of the cleaned up Real 
Time PCR positive products. For the Nested PCR the primer N-p24 E2 was used. The 
choosing of the primers has been made due to the primer design results. In this case the two 
primers p24 E and N-p24 E2 fulfilled the criteria for primer design at best. In both cases the 
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amplicons should be a partial sequence of the 16S rRNA gene of Bartonella and thus resulting 
only in a BLAST hit for Bartonella species. 
 
The result for the Real Time PCR 16s rRNA partial sequence with 384bp (Fig. 49 and 50): 
 
TGTCGCGGNNGTTGGGTTAACAAACGTAACGAGCGCAACCNCNCCCCTTAGTTGC
CAGCATTTAGTTGGGCACTCTAAGGGGACTGCCGGTGATAAGCCGAGAGGAAGG
TGGGGATGACGTCAAGTCCTCATGGCCCTTACGGGCTGGGCTACACACGTGCTAC
AATGGTGGTGACAGTGGGCAGCGAGACCGCGAGGTCGAGCTAATCTCCAAAAGC
CATCTCAGTTCGGATTGCACTCTGCAACTCGAGTGCATGAAGTTGGAATCGCTAG
TAATCGTGGATCAGCATGCCACGGTGAATACGTTCCCGGGCCTTGTACACACCGC
CCGTCACACCATGGGAGTTGGTTTTACCCGAAGGTGCTGTGCTACCGGCNAAGGA
A 
 
 
 
Fig. 49 Colour key for the alignment scores of the Real Time PCR positive results 
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Fig. 50 Scores for the BLAST of the Real Time PCR positive results 
 
 
The result for the Nested PCR 16s rRNA partial sequence with 380bp (Fig. 51 and 52): 
 
TACCCNGGNGGGGTGNNNGNTTNTACGNAANTGGATGAGCCCGCGTTGGATTAG
CTAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATCCATAGCTGGTCTGAGAG
GATGATCAGCCACACTGGGTACTGAGACACGGCCCAGACTCCTACGGGAGGCAG
GAGNGGGGAATATTGGACAATGGGGGCAACCCTGATCCAGCCATGCCGCGTGAG
TGATGAAGGCCCTAGGGTTGTAAAGCTCTTTCACCGGTGAAGATAATGACGGTAA
CCGGAGAAGAAGCCCCGGCTAACTTCGTGCCAGCAGCCGCGGTAATACGAAGGG
GGCTAGCGTTGTTCGGATTTACTGGGCGTAAAGCGCATGTAGGCGGATNATTTAA 
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Fig. 51 Colour key for the alignment scores of the Nested PCR positive results 
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Fig. 52 Scores for the BLAST of the Nested PCR positive results 
 
At the end of the sequencing, the BLAST results could confirm the outcomes of the PCR 
screenings. 
 
 
5.1.6. Indirect Immunofluorescence-Test 
 
For the IIF-Test 100 samples of each serum library (see Tab. 6) have been tested. This test 
was developed to detect in vitro human IgG – antibodies against Bartonella henselae and 
quintana in human serum or plasma. Two positive controls were used: one control with 
antibodies against B. henselae and the second with antibodies against B. quintana (Fig. 53). 
As a negative control an anti-Bartonella-negative solution was provided with the 
EUROIMMUN kit (Fig. 54). 
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Fig. 53 IIF-Test positive controls and positive samples 
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Fig. 54 IIF-Test negative controls 
 
Of the 200 tested sera 57 were positive (Fig. 55). The antibody titer was measured at 1/320 
and analysed with a UV-Microscope with 40x magnification. Of the reference serum library 
50 men and 50 women of different age have been chosen to receive a representative sample. 
In the case of the hunters, due to the fact that this profession is mainly a male domain, it was 
only possible to have 25% women in the sample. In order to compare the results between the 
two serum libraries with the inclusion of the gender it was necessary to construct a separate 
table (Fig. 56). The age of the donors reaches from 20 to 89 years. In the last table the focus 
lies on the positives in comparison with the age of the donors (Tab. 42). The results showed 
that the mean age with the highest risk to get infected was 38 years in the case of the blood 
donors and 45 years for hunters. The influence of hunters on these results, considered as a 
high risk group, can be ignored due to the results of this study. There was no significance that 
the infection rate of hunters is higher due to their overexposure to ticks. But the infection rate 
with B. quintana was much higher than with B. henselae. In the case of the gender 
comparison there was a slightly higher infection rate of the male patients especially with B. 
quintana. 
 
 
 
Tab. 42 IIF-Test results with an age comparison 
  
 
 
Page  103 
 
  
 
Fig. 55 IIF-Test results I 
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Fig. 56 IIF-Test results II with a gender comparison 
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6. Discussion 
 
The aim of this study was to found a proper screening method for Bartonella species in ticks. 
Furthermore the relevance of Ixodes ricinus as possible tick vector should be investigated. 
 
A PCR screening method was successfully found in the present study. Due to the results of 
the IIF screening there was no evidence that Ixodes ricinus serves as vector for Bartonella 
species. 
 
 
6.1. Tick DNA Extraction and Bartonella cultivation 
 
The tick DNA extraction with the DNeasy Blood and Tissue Kit after the protocol of Beati 
and Keirans resulted in a high yield [221]. It is a fast and reliable method to extract tick DNA. 
 
As stated of Heller and colleges Bartonella cultivation requires sensitive culture methods for 
the optimal recovery of these bacteria. They used blood agar plates for Bartonella cultivation 
but had problems to cultivate . clarridgeiae and hence had to work with a second cultivation 
method, the BACTEC Peds Plus vial (Becton Dickinson Diagnostic Instrument Systems, 
Sparks, Md.) [222]. 
In the present work even B. clarridgeiae could have been cultivated with blood agar plates. 
But there was a significant difference in the cultivation time. So if cultivating B. clarridgeiae 
it has to be considered that this species takes approximately 10 days longer for the first visible 
colonies.
 
 
6.2. PCRs 
 
Because of their fastidious nature, Bartonella species are difficult to differentiate on the basis 
of phenotypic properties; for example, all are more or less inert in the standard biochemical 
tests used in bacterial identification. However, a number of PCR-based methods for the 
identification and delineation of Bartonella species have been described, targeting a range of 
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genetic loci including fragments of 16S rRNA gene, the 16-23S rRNA gene intergenic 
transcribed spacer region (ITS), the citrate synthase-encoding gene (gltA), the 60-kDa 
heatshock protein-encoding gene (groEL), a cell division protein-encoding gene (ftsZ), the 
RNA polymerase beta subunit-encoding gene (rpoB) and others [23, 52, 158, 196, 216, 217, 
223, 224, 225]. So until now more than seven different target sequences and even more 
primer sets are in use. As a matter of fact, there is no standard procedure for the identification 
and delineation of Bartonella species. 
The primer design of this work showed good results for the Bartonella screening. The primer 
p24 E was used in the study of Relman et al and Schouls et al [23, 196]. As a second primer 
they used p12B which produced an amplicon of 241bp length. The short amplicon length 
especially with the 16S rRNA gene as a target sequence resulted in similarities with other 
eubacteria; especially Brucella abortus. To prevent these high similarities the second primer 
for this study, p24 E2, was designed in a more distant and specific location on the 16s rRNA 
gene. The resulting amplicon sequence was 437 to 438bp long with much fewer similarities to 
other eubacteria. 
Except from the primer set Bart 2 and 1R all primer pairs showed good results with a focus on 
p24 E and E2 (Tab. 43). But overall, after the results of this study, p24 E and E2 should be 
used for Bartonella screening in ticks. This would provide a good basis for a standard 
procedure for the identification and delineation of Bartonella species. 
 
 
Tab. 43 Overview primer sets with their target sequences 
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The ITS region, which lies between the 16S and 23S rRNA genes within the rRNA encoding 
operon, has been characterized in several Bartonella species and has been found to be 
somewhat larger than observed among other bacteria, ranging between 906 and 1529bp [217]. 
As most of the ITS is noncoding, it is prone to hyper-variability and thus interspecies and 
interstrain ITS sequence variation is markedly higher than that observed at other genetic loci 
[54]. Birtles and colleagues described the use of PCR-based amplification of ITS fragments to 
detect and identify Bartonellae in the blood of rodents. Direct detection was of particular use 
in the longitudinal survey of Bartonella bacteraemia that involved the field collection of very 
small amounts of blood from wild-living rodents [217, 223]. 
So the ITS region is a proper target sequence for Bartonella detection and differentiation. 
Results with the ITS region as target sequence couldn’t be achieved in this study do to 
unknown interference factors. As already mentioned in chapter 5.1.4.4 - PCR for species 
differentiation, the results of the primer design did not correlate with the PCR results. There 
should not occur any unspecific primer binding and hence no unwanted amplicon products. 
Step per step the primers had been tested again with good results. All reagents of the master-
mixture had been discarded and new ones have been used to eliminate the possibility of a 
contamination. Furthermore another laminar flow cabinet was used. But in the end the ITS - 
PCR screening results stayed non evaluable. 
However the Ixodes ricinus tick screening for the presence of Bartonella DNA showed good 
results with the new established PCRs. In the case of the Nested PCR 23 out of 216 ticks 
could have been tested Bartonella DNA. This corresponds to a percentage of 10.6%. The rate 
of infection had its highest level in female adult ticks and decreased from male adult ticks to 
nymphs and larvae. This tendency correlates with other studies like the one of Hercík and 
colleagues [226]. It was an Ixodid tick screening study of 2003-2005. 327 ticks have been 
collected in different urban and suburban areas of Czechia. Half of the collected ticks had 
been male and female adults and the other half nymphs. They used Nested PCR techniques 
with the 16S rRNA gen and the ITS region as a target sequence. It resulted in a rate of 
infection of 1.2%, 2 males, one female and one nymph. The infection rate was much lower 
than in Austria but the tendency was the same. This decrease of the rate of infection from 
adult ticks over nymphs to larvae had been observed in many studies [196, 199, 200, 202, 216 
226]. Especially the work of Halos and colleagues of France showed this significance. They 
had investigated 94 Ixodes ricinus ticks, 18 adults and 76 nymphs, in the Lille area in 2002. 
The screening was performed not only for Bartonella sp, but also for Borrelia burgdorferi 
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sensu lato and Babesia sp. For all three pathogens adult ticks showed a significantly higher 
infection rate with 67% compared to nymphs with 15% [202]. There are several hypotheses to 
explain this difference. One favoured explanation is the number of potentially infected meals 
which is higher for adults than for nymphs (two blood meals for adults versus one for 
nymphs). This could either be related to the existence of stage-specific factors, favouring the 
acquisition of the pathogen by the tick at a special stage as previously shown for other vector 
arthropods such as tsetse flies [202, 227]. 
The availability of improved molecular techniques for the characterization of Bartonellae led 
not only to changes in taxonomy but also promoted the discovery of several new species 
[217]. Today, an ever increasing number of Bartonellae, infecting a wide range of 
mammalian hosts, continue to be encountered [228, 229]. 
 
 
6.3. IIF-Screening 
 
For the IIF screening 200 sera had been tested with a EUROIMMUN dual kit. 57 of them 
were positive for Bartonella quintana and / or Bartonella henselae IgG – antibodies. The 
antibody titer was measured at a ratio of 1/320. With a focus on the age of the positive 
patients, the mean age for the highest risk to get infected was 38 years for the blood donors 
and 45 years for the hunters (Tab. 44). In the case of the gender comparison there was a 
slightly higher infection rate of the male patients especially with B. quintana of the hunters 
but with no significance due to the differing gender values of the hunters. 
 
 
 
Tab. 44 Overview results of the IIF - Assay 
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In the work of Yilmaz and colleagues the aim was to investigate the seroprevalence of B. 
henselae in volunteer blood donors and the related risk factors. Seropositivity was detected in 
6% (48/800) of the donors. This correlates with the findings of B. henselae positives in this 
study (see Tab. 44). But their study didn’t find any significant statistical differences in terms 
of age, sex, chronic disorders, sport activities, outside behaviours, being injured by any wild 
or domestic animals, working outdoors, geographical properties of the area of inhabitancy, 
hunting and travelling [230]. 
Pons and colleagues examined serum samples of 218 patients in their study. 99 were female 
and 119 male, with a mean age of 34 to 36 years (range 0–91 years). Nineteen (8.7%) reacted 
with B. henselae antigens. Of all the factors concerning the seroprevalence rate being studied 
(age, sex, contact with animals, residential area), only age was statistically significant. Their 
results show a good compliance to this work; especially their findings regarding the 
statistically significant association between B. henselae seropositivity and age. Their observed 
B. henselae seropositivity was significantly more prevalent in subjects aged 30 – 44 years 
[231]. 
Further seroprevalence values for B. henselae reported by other investigators: 30% by Sander 
et al. [232] in Germany, 19.8% by Tea et al. [233] in Greece, 24.7% by Garcia-Garcia et al. 
[234] in Sevilla, Spain, 3.0% by McGill et al. [235] in Sweden and 5.88% by Blanco Ramos 
[236] in La Rioja, Spain. Two of these studies also screened for B. quintana IgG antibodies 
with the following results: Tea et al. 15% [233] and McGill et al. 0.2%. So if these values are 
compared to the results of this study in Austria the seroprevalence has a much lower level 
than in most of the other European countries. Whereas the value of the Bartonella quintana 
seropositivity is higher than in Greece and especially than in Sweden. 
 
The influence of hunters on this works results, considered as a high risk group, can be 
ignored. There was no significance that the infection rate of hunters is higher due to their 
overexposure to ticks. 
But vector biologists and epidemiologists have suggested that ticks may have a role in 
Bartonella transmission [237]. In 1996 Kruszewska et al. reported the preliminary finding of a 
Bartonella strain in Ixodes ricinus ticks from a park in Walz, Poland [238]. Through 
restriction fragment length polymorphism – PCR (RFLP-PCR) it was detected as Bartonella 
bacilliformis. Unfortunately, the strain has not been further characterized. More recently, 
different Bartonella species, including B. quintana, B. henselae, B. washoensis, and B. 
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vinsonii suspecies berkhoffii, have been detected in 19.2% of Ixodes pacificus ticks collected 
in California by amplification and sequencing of a fragment of the gltA gene [198]. In a study 
conducted by Lucey et al. in 1992 ticks had been suspected of being vectors of B. henselae. 
The tested patients recalled a tick bite but had no history of cat contacts. The authors reported 
a high B. henselae bacteremia level in these patients [239]. Ticks were also reported as 
possible source of infection in some human cases of concurrent infections of the central 
nervous system by Borrelia burgdorferi and Bartonella henselae [197]. So the evidence that 
ticks may serve as Bartonella vectors appears to be rapidly accumulating. As a consequence I 
would not proclaim that ticks cannot serve as Bartonella vectors due to the results of this 
study. It only means that there was no significance in this test series. 
It will require much more work in the field of standardised Bartonella detection and 
differentiation methods as well as the construction of suitable test groups to verify if ticks 
serve as vector for Bartonella species. 
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7. Abstract in German 
 
DETEKTION VON PATHOGENEN BARTONELLA SPEZIES IN ÖSTERREICHISCHEN 
IXODES RICINUS ZECKEN 
 
Bartonellen sind Gram-negative, fakultativ-intrazelluläre aerobe Stäbchen-Bakterien und sind 
hauptsächlich als Erreger der Katzenkratzkrankheit bekannt, eine durch Bartonella henselae 
ausgelöste Erkrankung des Menschen, mit Lymphadenopathie und Fieber. Die Übertragung 
erfolgt entweder direkt über Katzen, welche für Bartonella henselae als Reservoirwirt dienen 
oder indirekt über den Katzenfloh. Mittlerweile hat man jedoch erkannt, dass viele weitere 
Bartonella-Spezies Bedeutung als Krankheitserreger des Menschen haben. Von den derzeit 
beschriebenen 24 Bartonella Arten sind zumindest 9 Arten humanpathogen. Bartonellen 
verursachen neben der Katzenkratzkrankheit auch die Carrión Krankheit, das 
Schützengrabenfieber (Trench fever), die Bazilläre Angiomatose, und Endokarditis. Auch 
Zecken kommen als Vektoren von Bartonellen in Betracht, wobei hier Risikogruppen wie 
Jäger und Forstarbeiter besonders hervorzuheben sind. Weitere Bartonella Vektoren neben 
der Zecke und dem Katzenfloh sind die Kleiderlaus und die Sandfliege. 
Das Ziel der vorliegenden Studie war es, die Durchseuchungsrate österreichischer Zecken mit 
Bartonellen zu erheben. Außerdem ist die Prävalenz von Antikörpern gegen Bartonellen in 
Risikogruppen (beispielsweise Jäger) ermittelt worden. Zunächst wurden zwei PCR-Systeme 
etabliert, welche es ermöglicht haben Bartonellen in Zecken und deren Wirten nachzuweisen. 
Ein Nested PCR Verfahren und eine Real Time PCR wurden eingesetzt und verglichen. Für 
den Nachweis und auch die Differenzierung der Bartonella Spezies wurden verschiedene 
Zielgene (16S rRNA, 16S-23S intergenic spacer) verwendet und jeweils spezifische Primer 
entwickelt. Die nötige Kontroll-DNA für die Etablierung der PCR und die weiterführenden 
Untersuchungen wurde aus Bartonella Kulturen gewonnen. Hierzu wurden Plattenkulturen 
der Arten Bartonella henselae, B. grahamii, B. doshiae und B. clarridgeiae angelegt. Die 
Bakterien wurden in der exponentiellen Wachstumsphase von den Platten geerntet und deren 
DNA isoliert. 
Aus allen 9 Bundesländern von Österreich gesammelte Adulte, Nymphen und Larven der 
Zecke Ixodes ricinus wurden auf Bartonella sp. untersucht. Von 216 getesteten Zecken 
Proben, bestehend aus 8 Adulten, 8 Nymphen und 8 Larven jedes Bundeslands, konnten 16 
Positive bei der Real Time PCR und 23 Positive bei der Nested PCR detektiert werden. Dies 
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entspricht einer Durchseuchungsrate von 7,4% im Falle der Real Time PCR und 10,4% bei 
der Nested PCR. Des Weiteren konnte gezeigt werden, dass die Durchseuchungsrate von 
Larven über Nymphen zu Adulten Zecken markant angestiegen ist. 
 
Im zweiten Teil der Arbeit wurden zwei Serotheken auf Antikörper gegen Bartonella getestet 
mithilfe eines Immunfluoreszenz Tests (IIF-Test für B. henselae und B. quintana IgG, 
Euroimmun Biochip Kit). Die erste Serothek bestand aus 891 Jäger Seren aus dem Jahr 2002 
und die Zweite, welche als Referenz verwendet wurde, aus 624 Seren von Blutspendern des 
Roten Kreuzes aus dem Jahr 2006. Das Resultat war eine leicht höhere Durchseuchungsrate 
innerhalb der Jäger als Risikogruppe; 13,5% seropositve Jäger im Vergleich zu 11,5% der 
Blutspender. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Page  113 
 
  
8. References 
 
[1] de Estete M.: Relacion del viaje de Hernando Pizarro (1553) as cited by Hermilio 
Valdizán in Apuntes para la Historia de la verruga peruana.“ Anal. Fac. Med. Lima 
10 (Suppl) (1925) 34-44 
[2] Allison M.J., Pezzia A., Gerszten E., Mendoza D.: A case of Carrión’s disease 
associated with human sacrifice from the Huari culture of southern Peru. Am. J. 
Phys. Anthropol. 41 (1985) 295-300 
[3]  Llanos-Cuentas E.A., Warrell D.A.: Bartonellose In: D.A. Warrell (Ed.): 
Infektionskrankheiten. Edition Medizin (1990) 461-463 
[4] Garcia-Caceres U., Garcia F.U.: Bartonellosis. An immunodepressiv disease and 
the life of Daniel Alcides Carrión. Am. J. Clin. Pathol. 95 (Suppl.1) (1991) 58-66 
[5] Manguina C.: Estudio de 23 casos de bartonellosis humana en San Marcos. 
Ancah. Diagnóstico 7 (6) (1981) 257-266 
[6] Manguina C., Pérez E.: La enfermedad de Carrión y leishmaniasis andina en la 
región de Conchucos, distrito de Chvin, San Marcos y Huantar, procinia de 
Huari, departamento de Ancash. Diagnóstico 16 (1) (1985) 5-12 
[7] Ellis B.A., Rotz L.D., Leake J.A., Samalvides F., Bernable J., Ventura G., Padilla C., 
Villaseca P., Beati L., Regnery R., Childs J.E., Olson J.G., Carillo C.P.: An 
outbreak of acute bartonellosis (Oroya fever) in the Urubamba region in Peru, 
1998. Am. J. Trop. Med. Hyg. 61 (1999) 344-349 
[8] Werner H., Haenssler E.: Über Fünftagefieber, febris quintana. Münch. Med. 
Wochenschrift 63 (1916) 1020-1023 
[9] Hurst A.: Trench fever. Br. Med. J. 25 (1042) 318–320 
[10] Kostrzewski J.: The epidemiology of trench fever. Bull. Acad. Pol. Sci. (Med.) 7 
(1949) 233-263 
[11] Munk F., da Rocha-Lima H.: Klinik und Ätiologie des sogen. "Wolhynischen 
Fiebers". (Werner-His’sche Krankheit) I. Klinischer Teil. Münch. Med. 
Wochenschrift 64 (42) (1917) 1357-1361 
[12] Garth J.: Tolkien and the Great War: The Threshold of Middle-earth. Houghton 
Mifflin Harcourt (2003) 
[13] Maurin M., Raoult D.: Bartonella (Rochalimaea) quintana Infections. Clinical 
Microbiology Reviews Vol. 9, No. 3 (1996) 273-292 
  
 
 
Page  114 
 
  
[14] Swift H. F.: Trench fever. Ann. Intern. Med. 26 (1920) 76–98. 
[15] Vinson J. W.: Louse-borne diseases world wide: trench fever. In Proceedings of 
the International Symposium on the Control of Lice and Louse-borne Diseases. Pan 
American Health Organisation, Washington, D.C. (1973) p. 76-79. 
[16] Butt H.T.: Trench fever in Salonica and France: observations of an outbreak of 
trench fever in the Salonica command. Med. J. S. Afr. 15 (1919) 230–250. 
[17] Coombs C.F.: The recurrent type of ―trench fever‖ in Mesopotamia. Lancet I 
(1917) 183. 
[18] Logan J.S.: Trench fever in Belfast and the nature of the relapsing fevers in the 
United Kingdom in the nineteenth century. Ulst. Med. J. 58 (1989) 83-88. 
[19] Bergwall B.: Fall av febris wolhynica. Sartryck Sven. Lakartidningen 52 (1945) 1–
4. 
[20] Mooser H., Leeman A., Chao S., and Gubler H.U.: Beobachtungen an 
Fünftagefieber. Schweiz. Z. Pathol. Bakteriol. 11 (1948) 513–522. 
[21] Raoult D., Ndihokubwayo J.B., Tissot-Dupont H., Roux V., Faugere B., Abegbinni 
R., Birtles R.J.: Outbreak of epidemic typhus associated with trench fever in 
Burundi.  The Lancet 352 (1998) 353-358. 
[22] Welch D.F., Pickett D.A., Slater L.N., Steigerwalt A.G., Brenner D.J.: Rochalimaea 
henselae sp. nov., a cause of septicemia, bacillary angiomatosis, and 
parenchymal bacillary peliosis. J. Clin. Microbiol. 30 (1992) 275-280. 
[23] Relman D.A., Loutit J.S., Schmidt T.M., Falkow S., Tompkins L.S.: The agent of 
bacillary angiomatosis. An approach to the identification of uncultured 
pathogens. N. Engl. J. Med. 323 (1990) 1573-1580. 
[24] Slater L.N., Welch D.F., Hensel D., Coody D.W.: A newly recognized fastidious 
gramnegative pathogen as a cause of fever and bacteremia. N. Engl. J. Med. 323 
(1990) 1587-1593. 
[25] Brenner D.J., O'Connor S.P.,Winkler H.H., Steigerwalt A.G.: Proposals to unify the 
genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana 
comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and 
Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from 
the order Rickettsiales. Intern. J. Syst. Bacteriol. 43 (1993) 777-786. 
[26] Schmincke R.A.: Histopathologischer Befund in Roseolen der Haut bei 
Wolhynischem Fieber. Münch. Med. Wochenschrift 64 (1917) 961. 
  
 
 
Page  115 
 
  
[27] Vinson J.W., Fuller H.S.: Studies on trench fever. 1. Propagation of Rickettsia-
like organisms form a patients blood. Pathol. Microbiol. 24 (1961) 152-166. 
[28] Chomel B.B., Kasten R.W., Floyed-Hawkins K., Chi-Yamamoto B., Roberts-Wilson 
J., Gurfield A.N., Abbott R.C., Pedersen N.C., Koehler J.E.: Experimental 
transmission of Bartonella henselae by the cat flea. J. Clin. Microbiol. 34 (1996) 
1952-1956. 
[29] Koehler J.E., Glaser C.A., Tappero J.W.: Rochalimaea henselae infection. A new 
zoonosis with the domestic cat as reservoir. J. Jama 271 (1994) 531-535. 
[30] Anderson B.E., Neuman M.A.: Bartonella spp. as emerging human pathogens. J. 
Clin. Microbiol. Rev 10 (1997) 203-219. 
[31] Fournier P.E., Lelievre H., Eykyn S.J., Mainardi J.L., Marrie T.J., Bruneel F., Roure 
C., Nash J., Clave D., James E., Benoit-Lemercier C., Deforges L., Tissot-Dupont H. 
and Raoult D.: (2001) Epidemiologic and clinical characteristics of Bartonella 
quintana and Bartonella henselae endocarditis: a study of 48 patients. J. 
Medicine (Baltimore) 80 (2001) 245-251. 
[32] Barton A.L.: Cuerpos endoglobulares en la sangre verrucosa. Gaceta de los 
Hospitales 18 (1905) 35-39. 
[33] Lawson P.A., Collins M.D.: Description of Bartonella clarridgeiae sp. nov. 
isolated from the cat of a patient with Bartonella henselae septicemia. Med. 
Microbiol. Lett. 5 (1996) 64-73. 
[34] Daly J.S., Worthington M.G., Brenner D.J., Moss C.W., Hollis D.G., Weyant R.S., 
Steigerwalt A.G., Weaver R.E., Daneshvar M.I., O’Connor S.P.: Rochalimaea 
elizabethae sp. nov. isolated from a patient with endocarditis. J. Clin. Microbiol. 
31 (1993) 872-881. 
[35] Birtles R.J., Harrison T.G., Saunders N.A., Molyneux D.H.: Proposals to unify the 
genera Grahamella and Bartonella, with descriptions of Bartonella talpae comb. 
nov., Bartonella peromysci comb. nov., and three new species, Bartonella 
grahammii sp. nov., Bartonella taylorii sp. nov., and Bartonella doshiae sp. nov. 
Int. J. Syst. Bacteriol. 45 (1995) 1-8. 
[36] Welch D.F., Carroll K.C., Hofmeister E.K., Persing D.H., Robinson D.A., 
Steigerwalt A.G., Brenner D.J.: Isolation of a new subspecies, Bartonella vinsonii 
subsp. arupensis, from a cattle rancher: identity with isolates found in 
  
 
 
Page  116 
 
  
conjunction with Borrelia burgdorferi and Babesia microti among naturally 
infected mice. J. Clin. Microbiol. 37 (1999) 2598-2601. 
[37] Kosoy M., Murray M., Bilmore R.E. Jr., Bai Y., Gage K.L.: Bartonella strains from 
ground squirrels are identical to Bartonella washoensis isolated from a human 
patient. J. Clin. Microbiol. 41 (2003) 645-50. 
[38] Heller R., Kubina M., Mariet P., Riegel P., Delacour G., Dehio C., Lamarque F., 
Kasten R., Boulouis H-J., Monteil H., Chomel B., Piemont Y.: Bartonella alsatica 
sp. nov., a new Bartonella species isolated from the blood of wild rabbits. Int. J. 
Syst. Bacteriol. 49 (1999) 283-288. 
[39] Bermond D., Heller R., Barrat F., Delacour G., Dehio C., Alliot A., Monteil H., 
Chomel B., Boulouis H-J., Piemont Y.: Bartonella birtlesii sp. nov., isolated from 
small mammals (Apodemus spp.). Int. J. Syst. Evol. Bacteriol. 50 (2000) 1973-
1979. 
[40] Bermond D., Boulouis H.J., Heller R., van Laere G., Dehio C., Monteil H., Chomel 
B.B., Sander A., Piemont Y.: Bartonella bovis Bermond et al. sp. nov. and 
Bartonella capreoli sp. nov., isolated from European ruminants. Int. J. Syst. Evol. 
Bacteriol. 52 (2002) 383-390. 
[41] Maillard R., Riegel P., Barrat F., Bouillin C., Thibault D., Gandoin C., Halos L., 
Demanche C., Alliot A., Guillot J., Piemont Y., Boulouis H.J., Vayssier-Taussat M.: 
Bartonella chomelii sp. nov., isolated from French domestic cattle (Bos taurus) 
Int. J. Syst. Evol. Microbiol. 54 (2004) 215-220. 
[42] Droz S., Chi B., Horn E., Steigerwalt A.G., Whitney A.M., Brenner D.J.: Bartonella 
koehlerae sp. nov., isolated from cats. J. Clin. Microbiol. 37 (1999) 1117-1122. 
[43] Tyzzer E.E.: A comparison study of Grahamellae, Haemobartonellae and 
Eperythrozoa in small mammals. Proc. Am. Phil. Soc. 85 (1942) 359-398. 
[44] Dehio C., Lanz C., Pohl R., Behrens P., Bermond D., Piemont Y., Pelz K., Sander 
A.: Description of a new Bartonella species, Bartonella schoenbuchii sp. nov., 
isolated from blood of wild roe deer. Int. J. Syst. Evol. Bacteriol. 51 (2001) 1557-
1565. 
[45] Brumpt E.: Note sur le parasite des hematies de la taupe: Grahamella talpae n.g. 
n.sp. Bull. soc. Pathol. Exot. 4 (1911) 514-517. 
[46] Heller R., Riegel Ph., Hausmann Y., Delacour G., Bermond D., Dehio C., Lamarque 
F., Monteil H., Chomel B., Piemont Y.: Bartonella tribocorum sp. nov., a new 
  
 
 
Page  117 
 
  
Bartonella species isolated from the blood of wild rats. Int. J. Syst. Bacteriol. 48 
(1998) 1333-1339. 
[47] Kordick D.L., Swaminathan B., Greene C.E., Wilson K.H., Whitney A.M., 
O’Connor S., Hollis D.G., Matar G.M., Steigerwalt A.G., Malcolm G.B., Hayes P.S., 
Hadfield T.L., Breitschwerdt E.B., Brenner D.J.: Bartonella vinsonii subsp. 
berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; 
and emended description of Bartonella vinsonii. Int. J. Syst. Bacteriol. 46 (1996) 
704-709. 
[48] Baker J.A.: A rickettsial infection in Canadian voles. J. Exp. Med. 84 (1946) 37-
50. 
[49] Eremeeva M.E., Gerns H.L., Lydy S.L., Goo J.S., Ryan E.T., Mathew S.S., Ferraro 
M.J., Holden J.M., Nicholson W.L., Dasch G.A., Koehler J.E.: Bacteremia, fever, 
and splenomegaly caused by a newly recognized Bartonella species. N. Engl. J. 
Med. 356 (2007) 2381-2387. 
[50] Maggi R.G., Kosoy M., Mintzer M., Breitschwerdt E.B.: Isolation of Candidatus 
Bartonella melophagi from human blood. J. Emer. Infect. Dis. 15 (2009) 66-68. 
[51] Gundi V.A., Davoust B., Khamis A., Boni M., Raoult D., La Scola B.: Isolation of 
Bartonella rattimassiliensis sp. nov. and Bartonella phoceensis sp. nov. from 
European Rattus norvegicus. J. Clin. Microbiol. 42 (2004) 3816-3818. 
[52] Zeaiter Z., Liang Z., Raoult D.: Genetic classification and differentiation of 
Bartonella species based on comparison of partial ftsZ gene sequences. 
J.Clin.Microbiol. 40 (2002) 3641-3647. 
[53] Reschke D.K., Frazier M.E., Mallavia L.P.: Transformation and genomic 
restriction mapping of Rochalimaea spp. Acta Virol 35 (1991) 519-525. 
[54] Roux V., Raoult D.: The 16S-23S rRNA intergenic spacer region of Bartonella 
(Rochalimaea) species is longer than usually described in other bacteria. Gene 
156 (1995) 107-111. 
[55] Roux V., Raoult D.: Inter- and intraspecies identification of Bartonella 
(Rochalimaea) species. J Clin Microbiol 33 (1995) 1573-1579. 
[56] Sander A., Ketzer S., Bredt W., Oberle K., Bereswill S.: Hemin-dependent growth 
and hemin binding of Bartonella henselae. FEMS Microbiology 189 (2000) 55-59. 
  
 
 
Page  118 
 
  
[57] Wong M.T., Thornton D.C., Kennedy R.C., Dolan M.J.: A chemically defined 
liquid medium that supports primary isolation of Rochalimaea (Bartonella) 
henselae from blood and tissue specimens. J Clin Microbiol 33 (1995) 742–744. 
[58] Sander A.: Microbiological diagnosis of Bartonella species and Afipia felis. In: 
Schmid A. (ed.): Bartonella and Afipia Species emphasizing Bartonella henselae. 
1st edition, Contrib Microbiol. Basel, Kargar (1998) 98-112 
[59] Schulein R., Seubert A., Gille C., Lanz C., Hansmann Y., Piemont Y., Dehio C.: 
Invasion and persistent intracellular colonization of erythrocytes. A unique 
parasitic strategy of the emerging pathogen Bartonella. J Exp Med 193 (2001) 
1077-1086. 
[60] Schulein R., Dehio C.: The VirB/VirD4 type IV secretion system of Bartonella is 
essential for establishing intraerythrocytic infection. Mol Microbiol 46 (2002) 
1053-1067. 
[61] Greub G., Raoult D.: Bartonella: new explanations for old diseases. J Med 
Microbiol 51 (2002) 915-923. 
[62] Koesling J., Aebischer T., Falch C., Schulein R., Dehio C.: Cutting edge: antibody-
mediated cessation of hemotropic infection by the intraerythrocytic mouse 
pathogen Bartonella grahamii. J Immunol 167 (2001) 11-14. 
[63] Regnery R.L., Rooney J.A., Johnson A.M., Nesby S.L., Manzewitsch P., Beaver K., 
Olson J.G.: Experimentally induced Bartonella henselae infections followed by 
challenge exposure and antimicrobial therapy in cats. Am J Vet Res 57 (1996) 
1714-1719. 
[64] Kosoy M.Y., Saito E.K., Green D., Marston E.L., Jones D.C., Childs J.E.: 
Experimental evidence of host specificity of Bartonella infection in rodents. 
Comp Immunol Microbiol Infect Dis 23 (2000) 221-238. 
[65] Boulouis H.J., Barrat F., Bermond D., Bernex F., Thibault D., Heller R., Fontaine 
J.J., Piemont Y., Chomel B.B.: Kinetics of Bartonella birtlesii infection in 
experimentally infected mice and pathogenic effect on reproductive functions. 
Infect Immun 69 (2001) 5313-5317. 
[66] Brouqui P., Raoult D.: Bartonella quintana invades and multiplies within 
endothelial cells in vitro and in vivo and forms intracellular blebs. Res Microbiol 
147 (1996) 719-731. 
  
 
 
Page  119 
 
  
[67] Dehio C., Meyer M., Berger J., Schwarz H., Lanz C.: Interaction of Bartonella 
henselae with endothelial cells results in bacterial aggregation on the cell surface 
and the subsequent engulfment and internalisation of the bacterial aggregate by 
a unique structure, the invasome. J Cell Sci 110 (1997) 2141-2154. 
[68] Dehio C.: Interactions of Bartonella henselae with vascular endothelial cells. 
Curr Opin Microbiol 2 (1999) 78-82. 
[69] Verma A., Davis G.E., Ihler G.M.: Infection of human endothelial cells with 
Bartonella bacilliformis is dependent on Rho and results in activation of Rho. 
Infect Immun 68 (2000) 5960-5969. 
[70] Dehio C.: Bartonella interactions with endothelial cells and erythrocytes. Trends 
Microbiol 9 (2001) 279-285. 
[71] Kempf V.A., Volkmann B., Schaller M., Sander C.A., Alitalo K., Riess T., 
Autenrieth I.B.: Evidence of a leading role for VEGF in Bartonella henselae-
induced endothelial cell proliferations. Cell Microbiol 3 (2001) 623-632. 
[72] Burgess A.W., Anderson B.E.: Outer membrane proteins of Bartonella henselae 
and their interaction with human endothelial cells. Microb Pathog 25 (1998) 157-
164. 
[73] Garcia F.U., Wojta J., Hoover R.L.: Interactions between live Bartonella 
bacilliformis and endothelial cells. J Infect Dis 165 (1992) 1138-1141. 
[74] Conley T., Slater L., Hamilton K.: Rochalimaea species stimulate human 
endothelial cell proliferation and migration in vitro. J Lab Clin Med 124 (1994) 
521-528. 
[75] Kirby J.E., Nekorchuk D.M.: Bartonella-associated endothelial proliferation 
depends on inhibition of apoptosis. Proc Natl Acad Sci USA 99 (2002) 4656-4661. 
[76] Dramsi S., Cossart P.: Intracellular pathogens and the actin cytoskeleton. Annu Rev 
Cell Dev Biol 14 (1998) 137-166. 
[77] Gaur D., Storry J.R., Reid M.E., Barnwell J.W., Miller L.H.: Plasmodium 
falciparum is able to invade erythrocytes through a trypsin-resistant pathway 
independent of glycophorin B. Infect Immun 71 (2003) 6742-6746. 
[78] Hoffbrand A.V:, Pettit J.E., Moss P.A.H.: Essential Haematology. Publisher Wiley-
Blackwell 4
th
 edition (2001) 16-25. 
  
 
 
Page  120 
 
  
[79] Seubert A., Schulein R., Dehio C.: Bacterial persistence within erythrocytes: a 
unique pathogenic strategy of Bartonella spp. Int J Med Microbiol 291 (2002) 
555-560. 
[80] Buckles E.L., McGinnis Hill E.: Interaction of Bartonella bacilliformis with 
human erythrocyte membrane proteins. Microb Pathog 29 (2000) 165-174. 
[81] Iwaki-Egawa S., Ihler G.M.: Comparison of the abilities of proteins from 
Bartonella bacilliformis and Bartonella henselae to deform red cell membranes 
and to bind to red cell ghost proteins. FEMS Microbiol Lett 157 (1997) 207-217. 
[82] Hendrix L.R.: Contact-dependent hemolytic activity distinct from deforming 
activity of Bartonella bacilliformis. FEMS Microbiol Lett 182 (2000) 119-124. 
[83] Walker T.S., Winkler H.H.: Bartonella bacilliformis: colonial types and 
erythrozyte adherence. Infect Immun 31 (1981) 480-486. 
[84] Benson L.A., Kar S., McLaughlin G., Ihler G.M.: Entry of Bartonella bacilliformis 
into erythrocytes. Infect Immun 54 (1986) 347-353. 
[85] Scherer D.C., DeBuron-Connors I., Minnick M.F.: Characterization of Bartonella 
bacilliformis flagella and effect of antiflagellin antibodies on invasion of human 
erythrocytes. Infect Immun 61 (1993) 4962-4971. 
[86] Mernaugh G., Ihler G:M.: Deformation factor: an extracellular protein 
synthesized by Bartonella bacilliformis that deforms erythrocyte membranes. 
Infect Immun 60 (1992) 937-943. 
[87] Minnick M.F., Mitchell S.J., McAllister S.J.: Cell entry and the pathogenesis of 
Bartonella infections. Trends Microbiol 4 (1996) 343-347. 
[88] Battisti J.M., Minnick M.F.: Development of a system for genetic manipulation of 
Bartonella bacilliformis. Appl Environ Microbiol 65 (1999) 3441-3448. 
[89] Minnick M.F., Anderson B.E.: Bartonella interactions with host cells. Subcell 
Biochem 33 (2000) 97-123. 
[90] Xu Y.H., Lu Z.Y., Ihler G.M.: Purification of deformin, an extracellular protein 
synthesized by Bartonella bacilliformis which causes deformation of erythrocyte 
membranes. Biochim Biophys Acta 1234 (1995) 173-183. 
[91] Derrick S.C., Ihler G.M.: Deformin, a substance found in Bartonella bacilliformis 
culture supernatants, is a small, hydrophobic molecule with an affinity for 
albumin. Blood Cells Mol Dis 27 (2001) 1013-1019. 
  
 
 
Page  121 
 
  
[92] Henderson I.R., Nataro J.P., Kaper J.B., Meyer T.F., Farrand S.K., Bruns D.L., 
Finlay B.B., St Geme J.W.3rd.: Renaming protein secretion in the gram-negative 
bacteria. Trends Microbiol 8 (2000) 352. 
[93] Lory S.: Secretion of proteins and assembly of bacterial surface organelles: 
shared pathways of extracellular protein targeting. Curr Opin Microbiol 1 (1998) 
27-35. 
[94] Pukatzki S., Ma A.T., Sturtevant D., Krastins B., Sarracino D., Nelson W.C., 
Heidelberg J.F., Mekalanos J.J.: Identification of a conserved bacterial protein 
secretion system in Vibrio cholerae using the Dictyostelium host model system. 
Proc Natl Acad Sci U S A 103 (2006) 1528–1533. 
[95] Mougous J.D., Cuff M.E., Raunser S., Shen A., Zhou M., Gifford C.A., Goodman 
A.L., Joachimiak G., Ordoñez C.L., Lory S., Walz T., Joachimiak A., Mekalanos 
J.J.: A virulence locus of Pseudomonas aeruginosa encodes a protein secretion 
apparatus. Science 312 (2006) 1526–1530. 
[96] Bingle L.E., Bailey C.M., Pallen M.J.: Type VI secretion: a beginner's guide. Curr 
Opin Microbiol 11 (2008) 3–8. 
[97] Schroder G., Dehio C.: Virulence-associated type IV secretion systems of 
Bartonella. Trends Microbiol 13 (2005) 336-342. 
[98] Dehio C.: Infection-associated type IV secretion systems of Bartonella and their 
diverse roles in host cell interaction. Cell Microbiol 10 (2008) 1591-1598. 
[99] Cascales E., Christie P.J.: The versatile bacterial type IV secretion systems. Nat 
Rev Microbiol 1 (2003) 137-149. 
[100] Christie P.J.: Type IV secretion: intercellular transfer of macromolecules by 
systems ancestrally related to conjugation machines. Mol Microbiol 40 (2001) 
294-305. 
[101] Christie P.J., Vogel J.P.: Bacterial type IV secretion: conjugation adapted to 
deliver effector molecules to host cells. Trends Microbiol 8 (2000) 354-360. 
[102] Dehio C.: Molecular and cellular basis of Bartonella pathogenesis. Annu Rev 
Microbiol 58 (2004) 365-390. 
[103] Seubert A., Hiestand R., de la Cruz F., Dehio C.: A bacterial conjugation 
machinery recruited for pathogenesis. Mol Microbiol 49 (2003) 1253-1266. 
[104] Schulein R., Guye P., Rhomberg T.A., Schmid M.C., Schroder G., Vergunst A.C., 
Carena I., Dehio C.: A bipartite signal mediates the transfer of type IV secretion 
  
 
 
Page  122 
 
  
substrates of Bartonella henselae into human cells. Proc Natl Acad Sci U S A 102 
(2005) 856-861. 
[105] Kerkhoff F.T., Bergmans A.M., van Der Zee A., Rothova A.: Demonstration of 
Bartonella grahamii DNA in ocular fluids of a patient with neuroretinitis. J Clin 
Microbiol 37 (1999) 4034-4038. 
[106] Birtles R.J., Raoult D.: The genera Afipia and Bartonella. Schmidt A. (ed): 
Bartonella and Afipia species emphasizing Bartonella henselae. Contrib Microbiol 
Basel, Karger 1 (1998) 1-31. 
[107] Reynafarje C., Ramos J.: The hemolytic anemia of human bartonellosis. Blood 17 
(1961) 562-578. 
[108] Ihler G.M.: Bartonella bacilliformis: dangerous pathogen slowly emerging from 
deep background. FEMS Microbiol Lett 144 (1996) 1-11. 
[109] Arias-Stella J., Lieberman P.H., Erlandson R.A., Arias-Stella J. Jr.: Histology, 
immunohistochemistry, and ultrastructure of the verruga in Carrion's disease. 
Am J Surg Pathol 10 (1986) 595-610. 
[110] Ristic M., Kreier J.P.: Hemotropic bacteria. N Engl J Med 301 (1979) 937-939. 
[111] Bass J.W., Vincent J.M., Person D.A.: The expanding spectrum of Bartonella 
infections: I. Bartonellosis and trench fever. Pediatr Infect Dis J 16 (1997) 2-10. 
[112] Clarridge J.E. 3rd, Raich T.J., Pirwani D., Simon B., Tsai L., Rodriguez-Barradas 
M.C., Regnery R., Zollo A., Jones D.C., Rambo C.: Strategy to detect and identify 
Bartonella species in routine clinical laboratory yields Bartonella henselae from 
human immunodeficiency virus-positive patient and unique Bartonella strain 
from his cat. J Clin Microbiol 33 (1995) 2107-2113. 
[113] Kordick D.L., Hilyard E.J., Hadfield T.L., Wilson K.H., Steigerwalt A.G., Brenner 
D.J., Breitschwerdt E.B.: Bartonella clarridgeiae, a newly recognized zoonotic 
pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch 
disease). J Clin Microbiol 35 (1997) 1813-1818. 
[114] Margileth A.M., Baehren D.F.: Chest-wall abscess due to cat-scratch disease 
(CSD) in an adult with antibodies to Bartonella clarridgeiae: case report and 
review of the thoracopulmonary manifestations of CSD. Clin Infect Dis 27 (1998) 
353-357. 
[115] Debre R., Lamy M., Jammet M.L., Costil L., Mozzinacocci P.: La maladie des 
griffes du chat (Cat scratch disease). Sem Hop 40 (1950) 1895–1904. 
  
 
 
Page  123 
 
  
[116] Avidor B., Kletter Y., Abulafia S., Golan Y., Ephros M., Giladi M.: Molecular 
diagnosis of cat scratch disease: a two-step approach. J Clin Microbiol 35 (1997) 
1924–1930. 
[117] Regnery R.L., Olson J.G., Perkins B.A., Bibb W.: Serologic response to 
―Rochalimaea henselae‖ antigen in suspected cat scratch disease. Lancet 339 
(1992) 1443–1445. 
[118] Sander A., Posselt M., Bohm N., Ruess M., Altwegg M.: Detection of Bartonella 
henselae DNA by two different PCR assays and determination of the genotypes 
of strains involved in histologically defined cat scratch disease. J Clin Microbiol 
37 (1999) 993–997. 
[119] Zeaiter Z., Fournier P.E., Greub G., Raoult D.: Diagnosis of Bartonella 
endocarditis by a real-time nested PCR assay using serum. J Clin Microbiol 41 
(2003) 919–925. 
[120] Moriarty R.A., Margileth A.M.: Cat scratch disease. Infect Dis Clin North Am 1 
(1987) 575-590. 
[121] Jackson L.A., Perkins B.A., Wenger J.D.: Cat scratch disease in the United States: 
an analysis of three national databases. Am J Public Health 83 (1993) 1707-1711. 
[122] Jameson P., Greene C., Regnery R., Dryden M., Marks A., Brown J., Cooper J., 
Glaus B., Greene R.: Prevalence of Bartonella henselae antibodies in pet cats 
throughout regions of North America. J Infect Dis 172 (1995) 1145-1149. 
[123] Dalton M.J., Robinson L.E., Cooper J., Regnery R.L., Olson J.G., Childs J.E.: Use of 
Bartonella antigens for serologic diagnosis of cat-scratch disease at a national 
referral center. Arch Intern Med 155 (1995) 1670-1676. 
[124] Carithers H.A.: Cat-scratch disease. An overview based on a study of 1,200 
patients. Am J Dis Child 139 (1985) 1124-1133. 
[125] Bass J.W., Vincent J.M., Person D.A.: The expanding spectrum of Bartonella 
infections: II. Cat-scratch disease. Pediatr Infect Dis J 16 (1997) 163-179. 
[126] Hamilton D.H., Zangwill K.M., Hadler J.L., Cartter M.L.: Cat-scratch disease—
Connecticut, 1992-1993. J Infect Dis 172 (1995) 570-573. 
[127] Cunningham E.T., Koehler J.E.: Ocular bartonellosis. Am J Ophthalmol 130 (2000) 
340-349. 
  
 
 
Page  124 
 
  
[128] Fournier P.E., Raoult D.: Cat-scratch disease and an overview of other Bartonella 
henselae-related infections. Schmidt A. (ed.): Bartonella and Afipia Species 
emphasizing Bartonella henselae. Contrib Microbiol Basel, Karger 1 (1998) 32-62. 
[129] Margileth A.M.: Cat scratch disease. Adv Pediatr Infect Dis 8 (1993) 1-21. 
[130] Margileth A.M., Hayden G.F.: Cat scratch disease. From feline affection to 
human infection. N Engl J Med 329 (1993) 53-54. 
[131] Arvand M., Wendt C., Regnath T., Ullrich R., Hahn H.: Characterization of 
Bartonella henselae isolated from bacillary angiomatosis lesions in a human 
immunodeficiency virus-infected patient in Germany. Clin Infect Dis 26 (1998) 
1296-1299. 
[132] Koehler J.E., Quinn F.D., Berger T.G., LeBoit P.E., Tappero J.W.: Isolation of 
Rochalimaea species from cutaneous and osseous lesions of bacillary 
angiomatosis. N Engl J Med 327 (1992) 1625-1631. 
[133] Koehler J.E., Sanchez M.A., Garrido C.S., Whitfeld M.J., Chen F.M., Berger T.G., 
Rodriguez-Barradas M.C., LeBoit P.E., Tappero J.W.: Molecular epidemiology of 
Bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J 
Med 337 (1997) 1876-1883. 
[134] Ahsan N., Holman M.J., Riley T.R., Abendroth C.S., Langhoff E.G., Yang H.C.: 
Peloisis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-
renal syndrome. Transplantation 65 (1998) 1000-1003. 
[135] LeBoit P.E., Berger T.G., Egbert B.M., Beckstead J.H., Yen T.S., Stoler M.H.: 
Bacillary angiomatosis. The histopathology and differential diagnosis of a 
pseudoneoplastic infection in patients with human immunodeficiency virus 
disease. Am J Surg Pathol 13 (1989) 909-920. 
[136] Cockerell C.J.: Bacillary Angiomatosis and related diseases caused by 
Rochalimaea. J Am Acad Dermatol 32 (1995) 783-790. 
[137] Koehler J.E., LeBoit P.E., Egbert B.M., Berger T.G.: Cutaneous vascular lesions 
and disseminated cat-scratch disease in patients with the acquired 
immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med 
109 (1988) 449-455. 
[138] Marasco W.A., Lester S., Parsonnet J.: Unusual presentation of cat scratch disease 
in a patient positive for antibody to the human immunodeficiency virus. Rev 
Infect Dis 11 (1989) 793-803. 
  
 
 
Page  125 
 
  
[139] Milam M.W., Balerdi M.J., Toney J.F., Foulis P.R., Milam C.P., Behnke R.H.: 
Epithelioid angiomatosis secondary to disseminated cat scratch disease 
involving the bone marrow and skin in a patient with acquired immune 
deficiency syndrome: a case report. Am J Med 88 (1990) 180-183. 
[140] Rolain J.M., Brouqui P., Koehler J.E., Maguina C., Dolan M.J., Raoult D.: 
Recommendations for treatment of human infections caused by Bartonella 
species. Antimicrob Agents Chemother 48 (2004) 1921-1933. 
[141] Koehler J.E., Tappero J.W.: Bacillary angiomatosis and bacillary peliosis in 
patients infected with human immunodeficiency virus. Clin Infect Dis 17 (1993) 
612-624. 
[142] Slater L.N., Coody D.W., Woolridge L.K., Welch D.F.: Murine antibody responses 
distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol 
30 (1992) 1722-1727. 
[143] Slater L.N., Welch D.F., Min K.W.: Rochalimaea henselae causes bacillary 
angiomatosis and peliosis hepatis. Arch Intern Med 152 (1992) 602-606. 
[144] Lepidi H., Fournier P.E., Raoult D.: Quantitative analysis of valvular lesions 
during Bartonella endocarditis. Am J Clin Pathol 114 (2000) 880-889. 
[145] Liberto M.C., Matera G.: Pathogenic mechanisms of Bartonella quintana. New 
Microbiol 23 (2000) 449-456. 
[146] Maurin M., Birtles R., Raoult D.: Current knowledge of Bartonella species. Eur J 
Clin Microbiol Infect Dis 16 (1997) 487-506. 
[147] Foucault C., Brouqui P., Raoult D.: Bartonella quintana characteristics and 
clinical management. Emerg Infect Dis 12 (2006) 217-223. 
[148] Cockerell C.J., LeBoit P.E.: Bacillary angiomatosis: a newly characterized, 
pseudoneoplastic, infectious, cutaneous vascular disorder. J Am Acad Dermatol 
22 (1990) 501-512. 
[149] Adal K.A., Cockerell C.J., Petri W.A., Jr.: Cat scratch disease, bacillary 
angiomatosis, and other infections due to Rochalimaea. N Engl J Med 330 (1994) 
1509-1515. 
[150] Schmidt H.U., Kaliebe T., Poppinger J., Buhler C., Sander A.: Isolation of 
Bartonella quintana from an HIV-positive patient with bacillary angiomatosis. 
Eur J Clin Microbiol Infect Dis 15 (1996) 736-741. 
  
 
 
Page  126 
 
  
[151] Daly J.S., Worthington M.G., Brenner D.J., Moss C.W., Hollis D.G., Weyant R.S., 
Steigerwalt A.G., Weaver R.E., Daneshvar M.I., O’Conner S.P.: Rochalimaea 
elizabethae sp. nov. isolated from a patient with endocarditis. J Clin Microbiol 31 
(1993) 872-881. 
[152] O’Halloran H.S., Draud K., Minix M., Rivard A.K., Pearson P.A.: Leber's 
neuroretinitis in a patient with serologic evidence of Bartonella elizabethae. 
Retina 18 (1998) 276-278. 
[153] Serratrice J., Rolain J.M., Granel B., Ene N., Conrath J., Avierinos J.F., Disdier P., 
Raoult D., Weiller P.J.: [Bilateral retinal artery branch occlusions revealing 
Bartonella grahamii infection]. Rev Med Interne 24 (2003) 629-630. 
[154] Fenollar F., Sire S., Raoult D.: Bartonella vinsonii subsp. arupensis as an agent of 
blood culture-negative endocarditis in a human. J Clin Microbiol 43 (2005) 945-
947. 
[155] Dehio M., Knorre A., Lanz C., Dehio C.: Construction of versatile high-level 
expression vectors for Bartonella henselae and the use of green fluorescent 
protein as a new expression marker. Gene 215 (1998) 223-229. 
[156] Lee A.K., Falkow S.: Constitutive and inducible green fluorescent protein 
expression in Bartonella henselae. Infect Immun 66 (1998) 3964-3967. 
[157] Rolain J.M., Novelli S., Ventosilla P., Maguina C., Guerra H., Raoult D.: 
Immunofluorescence detection of Bartonella bacilliformis flagella in vitro and in 
vivo in human red blood cells as viewed by laser confocal microscopy. Ann N Y 
Acad Sci 990 (2003) 581-584. 
[158] Johnson G., Ayers M., McClure S.C., Richardson S.E., Tellier R.: Detection and 
identification of Bartonella species pathogenic for humans by PCR amplification 
targeting the riboflavin synthase gene (ribC). J Clin Microbiol 41 (2003) 1069-
1072. 
[159] Bereswill S., Hinkelmann S., Kist M., Sander A.: Molecular analysis of riboflavin 
synthesis genes in Bartonella henselae and use of the ribC gene for 
differentiation of Bartonella species by PCR. J Clin Microbiol 37 (1999) 3159-
3166. 
[160] Bergmans A.M., Peeters M.F., Schellekens J.F., Vos M.C., Sabbe L.J., Ossewaarde 
J.M., Verbakel H., Hooft H.J., Schouls L.M.: Pitfalls and fallacies of cat scratch 
  
 
 
Page  127 
 
  
disease serology: evaluation of Bartonella henselae-based indirect fluorescence 
assay and enzyme-linked immunoassay. J Clin Microbiol 35 (1997) 1931-1937. 
[161] Anderson B., Sims K., Regnery R., Robinson L., Schmidt M.J., Goral S., Hager C., 
Edwards K.: Detection of Rochalimaea henselae DNA in specimens from cat 
scratch disease patients by PCR. J Clin Microbiol 32 (1994) 942-948. 
[162] Goldenberger D., Schmidheini T., Altwegg M.: Detection of Bartonella henselae 
and Bartonella quintana by a simple and rapid procedure using broad-range 
PCR amplification and direct single-strand sequencing of part of the 16S rRNA 
gene. Clin Microbiol Infect 3 (1997) 240-245. 
[163] Tierno P.M., Jr: Diagnostics of human infections caused by Bartonella henselae. 
Schmidt A. (ed): Bartonella and Afipia species emphasizing Bartonella henselae. 
Contrib Microbiol Basel, Karger 1 (1998) 113-129. 
[164] Hansmann Y., DeMartino S., Piemont Y., Meyer N., Mariet P., Heller R., 
Christmann D., Jaulhac B.: Diagnosis of cat scratch disease with detection of 
Bartonella henselae by PCR: a study of patients with lymph node enlargement. J 
Clin Microbiol 43 (2005) 3800-3806. 
[165] Tang Y.W.: Duplex PCR assay simultaneously detecting and differentiating 
Bartonella quintana, B. henselae, and Coxiella burnetii in surgical heart valve 
specimens. J Clin Microbiol 47 (2009) 2647-2650. 
[166] Foucault C., Brouqui P., Raoult D.: Bartonella quintana characteristics and 
clinical management. Emerg Infect Dis 12 (2006) 217-223. 
[167] Piemont Y., Heller R.: [Bartonellosis. II. Other Bartonella responsible for human 
diseases]. Ann Biol Clin (Paris) 57 (1999) 29-36. 
[168] Ohl M.E., Spach D.H.: Bartonella quintana and urban trench fever. Clin Infect 
Dis 31 (2000) 131-135. 
[169] Raoult D., Fournier P.E., Vandenesch F., Mainardi J.L., Eykyn S.J., Nash J., James 
E., Benoit-Lemercier C., Marrie T.J.: Outcome and treatment of Bartonella 
endocarditis. Arch Intern Med 163 (2003) 226-230. 
[170] Perkocha L.A., Geaghan S.M., Yen T.S., Nishimura S.L., Chan S.P., Garcia-
Kennedy R., Honda G., Stoloff A.C., Klein H.Z., Goldman R.L.: Clinical and 
pathological features of bacillary peliosis hepatis in association with human 
immunodeficiency virus infection. N Engl J Med 323 (1990) 1581-1586. 
  
 
 
Page  128 
 
  
[171] Chia J.K., Nakata M.M., Lami J.L., Park S.S., Ding J.C.: Azithromycin for the 
treatment of cat-scratch disease. Clin Infect Dis 26 (1998) 193-194. 
[172] Maurin M., Raoult D.: Use of aminoglycosides in treatment of infections due to 
intracellular bacteria. Antimicrob Agents Chemother 45 (2001) 2977-2986. 
[173] Cross J.T., Jacobs R.F.: Tularemia: treatment failures with outpatient use of 
ceftriaxone. Clin Infect Dis 17 (1993) 976-980. 
[174] Battisti J.M., Smitherman L.S., Samuels D.S., Minnick M.F.: Mutations in 
Bartonella bacilliformis gyrB confer resistance to coumermycin A1. Antimicrob 
Agents Chemother 42 (1998) 2906-2913. 
[175] Bowman A.S., Nuttall P.A.: Ticks – Biology, Disease and Control. Cambridge 
University Press (2008). 
[176] Miller H.C., Conrad A.M., Barker S.C., Daugherty C.H.: Distribution and 
phylogenetic analyses of an endangered tick. New Zealand J Zoology 34 (2007) 
97-105. 
[177] Black W.C. th, Klompen J.S., Keirans J.E.: Phylogenetic relationships among tick 
subfamilies (Ixodida: Ixodidae: Argasidae) based on the 18S nuclear rDNA gene. 
Mol Phylogenet Evol 7 (1997) 129-144. 
[178] Süss J.: Durch Zecken übertragbare Erkrankungen: FSME und Lyme-
Borreliose. Weller Verlag (1995). 
[179] Roberts F.H.S.: Australian ticks. CSIRO (1970). 
[180] Klompen J.S., Black W.C. th, Keirans J.E., Oliver J.H. Jr.: Evolution of ticks. Annu 
Rev Entomol 41 (1996) 141-161. 
[181] Liebisch A., Liebisch G.: Zeckenborreliose Lyme-Krankheit beim Tier. Spitta 
Verlag (2003) 6-70. 
[182] Stanek G.: [Pandora's Box: pathogens in Ixodes ricinus ticks in Central Europe]. 
Wien Klin Wochenschr 121 (2009) 673-683. 
[183] Gray J.S.: The development and seasonal activity of the tick Ixodes ricinus: a 
vector of Lyme borreliosis. Rev Med Vet Entomol 79 (1991) 323-333. 
[184] Eckert J., Friedhoff K.T., Zahner H., Deplazes P.: Lehrbuch der Parasitologie für 
die Tiermedizin. Enke Verlag (2008) 376-392. 
[185] Anderson J.F.: Epizootiology of Borrelia in Ixodes tick vectors and reservoir 
hosts. Rev Infect Dis 11 Suppl 6 (1989) 1451-1459. 
  
 
 
Page  129 
 
  
[186] Gern L., Estrada-Pena A., Frandsen F., Gray J.S., Jaenson T.G., Jongejan F., Kahl 
O., Korenberg E., Mehl R., Nuttall P.A.: European reservoir hosts of Borrelia 
burgdorferi sensu lato. Zentralbl Bakteriol 287 (1998) 196-204. 
[187] Gray J.S.: The ecology of ticks transmitting Lyme borreliosis. Exp Appl Acarol 22 
(1998) 249-258. 
[188] Sonenshine D.E.: Biology of ticks Vol 2. Oxford University Press (1993). 
[189] Süss J., Schrader C.: [Tick-borne human pathogenic microorganisms found in 
Europe and those considered nonpathogenic. Part I: Ticks and Viruses]. 
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47 (2004) 392-
404. 
[190] Sonenshine D.E.: Biology of ticks Vol 1. Oxford University Press (1991). 
[191] Buczek A., Magdon T.: [Host location by ticks (Acari: Ixodida)]. Wiad Parazytol 
45 (1999) 3-12. 
[192] Lengauer H., Just F.T., Edelhofer R., Pfister K.: [Tick infestation and the 
prevalence of Borrelia burgdorferi and Babesia divergens in cattle in Bavaria]. 
Berl Munch Tierarztl Wochenschr 119 (2006) 335-341. 
[193] Parola P., Raoult D.: Ticks and tickborne bacterial diseases in humans: an 
emerging infectious threat. Clin Infect Dis 32 (2001) 897-928. 
[194] Gray J.S.: Biology of Ixodes species ticks in relation to tick-borne zoonoses. Wien 
Klin Wochenschr 114 (2002) 473-478. 
[195] Sparagano O., Jongejan F.: Molecular characterization of ticks and tick-borne 
pathogens. Parassitologia 41 Suppl 1 (1999) 101-105. 
[196] Schouls L.M., Van De Pol I., Rijpkema S.G., Schot C.S.: Detection and 
identification of Ehrlichia, Borrelia burgdorferi sensu lato, and Bartonella 
species in Dutch Ixodes ricinus ticks. J Clin Microbiol 37 (1999) 2215-2222. 
[197] Eskow E., Rao R.V., Mordechai E.: Concurrent infection of the central nervous 
system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel 
tick-borne disease complex. Arch Neurol 58 (2001) 1357-1363. 
[198] Chang C.C., Chomel B.B., Kasten R.W., Romano V., Tietze N.: Molecular evidence 
of Bartonella spp. in questing adult Ixodes pacificus ticks in California. J Clin 
Microbiol 39 (2001) 1221-1226. 
  
 
 
Page  130 
 
  
[199] Chang C.C., Hayashidani H., Pusterla N., Kasten R.W., Madigan J.E., Chomel B.B.: 
Investigation of Bartonella infection in ixodid ticks from California. Comp 
Immunol Microbiol Infect Dis 25 (2002) 229-236. 
[200] Sanogo Y.O., Zeaiter Z., Caruso G., Merola F., Shpynov S., Brouqui P., Raoult D.: 
Bartonella henselae in Ixodes ricinus ticks (Acari: Ixodida) removed from 
humans, Belluno province, Italy. Emerg Infect Dis 9 (2003) 329-332. 
[201] Adelson M.E., Rao R.V., Tilton R.C., Cabets K., Eskow E., Fein L., Occi J.L., 
Mordechai E.: Prevalence of Borrelia burgdorferi, Bartonella spp., Babesia 
microti, and Anaplasma phagocytophila in Ixodes scapularis ticks collected in 
Northern New Jersey. J Clin Microbiol 42 (2004) 2799-2801. 
[202] Halos L., Jamal T., Maillard R., Beugnet F., Le Menach A., Boulouis H.J., Vayssier-
Taussat M.: Evidence of Bartonella sp. in questing adult and nymphal Ixodes 
ricinus ticks from France and co-infection with Borrelia burgdorferi sensu lato 
and Babesia sp. Vet Res 36 (2005) 79-87. 
[203] Telford S.R., Wormser G.P.: Bartonella spp. transmission by ticks not established. 
Emerg Infect Dis 16 (2010) 379-384. 
[204] Raoult D., Roux V.: Rickettsioses as paradigms of new or emerging infectious 
diseases. Clin Microbiol Rev 10 (1997) 694-719. 
[205] Benson M.J., Gawronski J.D., Eveleigh D.E., Benson D.R.: Intracellular symbionts 
and other bacteria associated with deer ticks (Ixodes scapularis) from Nantucket 
and Wellfleet, Cape Cod, Massachusetts. Appl Environ Microbiol 70 (2004) 616-
620. 
[206] Huarcaya E., Maguina C., Torres R., Rupay J., Fuentes L.: Bartonelosis (Carrion's 
Disease) in the pediatric population of Peru: an overview and update. Braz J 
Infect Dis 8 (2004) 331-339. 
[207] Mogollon-Pasapera E., Otvos L. Jr., Giordano A., Cassone M.: Bartonella: 
emerging pathogen or emerging awareness? Int J Infect Dis 13 (2009) 3-8. 
[208] Maguina C., Guerra H., Ventosilla P.: Bartonellosis. Clin Dermatol 27 (2009) 271-
280. 
[209] Innis M.A., Gelfand D.H.: Optimization of PCRs. In: PCR protocols. A guid to 
methods and applications. Academic Press Chapter 1 (1990) 3-12. 
  
 
 
Page  131 
 
  
[210] Rychlik W., Spencer W.J., Rhoads R.E.: Optimization of the annealing 
temperature for DNA amplification in vitro. Nucleic Acids Res 18 (1990) 6409-
6412. 
[211] Rybicki E.: PCR primer design and reaction optimization. In: Molecula Biology 
Techniques Manual. Department of Molecular and Cell Biology, University of Cape 
Town (2001). 
[212] Schild T.: Einführung in die Real-Time TaqManTM PCR-Technologie. Ver. 2.1 
Applied Biosystems GmbH Weiterstadt 
[213] Kreuzer K.A., Bohn A., Lupberger J., Solassol J., le Coutre J., Schmidt C.A.: 
Simultaneous absolute quantification of target and control templates by real-
time fluorescence reverse transcription-PCR using 4-(4'-
dimethylaminophenylazo)benzoic acid as a dark quencher dye. Clin Chem 47 
(2001) 486-490. 
[214] Müller H.J.: Polymerase-Kettenreaktion (PCR). Berlin: Spektrum, Akad. Verl. 
(2001). 
[215] Freeman W.M., Walker S.J., Vrana K.E.: Quantitative RT-PCR: pitfalls and 
potential. Biotechniques 26 (1999) 112-122 and 124-125. 
[216] Kim C.M., Kim J.Y., Yi Y.H., Lee M.J., Cho M.R., Shah D.H., Klein T.A., Kim 
H.C., Song J.W., Chong S.T., O’Guinn M.L., Lee J.S., Lee I.Y., Park J.H., Chae J.S.: 
Detection of Bartonella species from ticks, mites and small mammals in Korea. J 
Vet Sci 6 (2005) 327-334. 
[217] Knap N., Duh D., Birtles R., Trilar T., Petrovec M., Avsic-Zupanc T.: Molecular 
detection of Bartonella species infecting rodents in Slovenia. FEMS Immunol 
Med Microbiol 50 (2007) 45-50. 
[218] Sanger F., Nicklen S., Coulson A.R.: DNA sequencing with chain-terminating 
inhibitors. Proc Natl Acad Sci U S A 74 (1977) 5463-5467. 
[219] Mosaik: Bartonella henselae / Bartonella quintana (IgG) – Anleitung für den 
indirekten Immunfluoreszenztest. EUROIMMUN Medizinische Labordiagnostika 
AG, Lübeck, Stand 13.12.2007. 
[220] Bustin S.A., Nolan T.: Pitfalls of quantitative real-time reverse-transcription 
polymerase chain reaction. J Biomol Tech 15 (2004) 155-166. 
[221] Beati L., Keirans J.E.: Analysis of the systematic relationships among ticks of the 
genera Rhipicephalus and Boophilus (Acari: Ixodidae) based on mitochondrial 
  
 
 
Page  132 
 
  
12S ribosomal DNA gene sequences and morphological characters. J Parasitol 87 
(2001) 32-48. 
[222] Heller R., Artois M., Xemar V., De Briel D., Gehin H., Jaulhac B., Monteil H., 
Piemont Y.: Prevalence of Bartonella henselae and Bartonella clarridgeiae in 
stray cats. J Clin Microbiol 35 (1997) 1327-1331. 
[223] Birtles R.J., Hazel S., Bown K., Raoult D., Begon M., Bennett M.: Subtyping of 
uncultured bartonellae using sequence comparison of 16 S/23 S rRNA intergenic 
spacer regions amplified directly from infected blood. Mol Cell Probes 14 (2000) 
79-87. 
[224] Houpilian P., Raoult D.: 16S/23S rRNA intergenic spacer regions for 
phylogenetic analysis, identification, and subtyping of Bartonella species. J Clin 
Microbiol 39 (2001) 2768-2778. 
[225] Houpilian P., Raoult D.: Molecular phylogeny of the genus Bartonella: what is the 
current knowledge? FEMS Microbiol Lett 200 (2001) 1-7. 
[226] Hercik K., Hasova V., Janecek J., Branny P.: Molecular evidence of Bartonella 
DNA in ixodid ticks in Czechia. Folia Microbiol (Praha) 52 (2007) 503-509. 
[227] Nantulya V.M., Doyle J.J., Jenni L.: Studies on Trypanosoma (nannomonas) 
congolense II. Observations on the cyclical transmission of three field isolates by 
Glossina morsitans morsitans. Acta Trop 35 (1978) 339-344. 
[228] Birtles R.J., Canales J., Ventosilla P., Alvarez E., Guerra H., Llanos-Cuentas A., 
Raoult D., Doshi N., Harrison T.G.: Survey of Bartonella species infecting 
intradomicillary animals in the Huayllacallan Valley, Ancash, Peru, a region 
endemic for human bartonellosis. Am J Trop Med Hyg 60 (1999) 799-805. 
[229] Breitschwerdt E.B., Kordick D.L.: Bartonella infection in animals: carriership, 
reservoir potential, pathogenicity, and zoonotic potential for human infection. 
Clin Microbiol Rev 13 (2000) 428-438. 
[230] Yilmaz C., Ergin C., Kaleli I.: [Investigation of Bartonella henselae 
seroprevalence and related risk factors in blood donors admitted to Pamukkale 
University Blood Center]. Microbiyol Bul 43 (2009) 391-401. 
[231] Pons I., Sanfeliu I., Cardenosa N., Nogueras M.M., Font B., Segura F.: Serological 
evidence of Bartonella henselae infection in healthy people in Catalonia, Spain. 
Epidemiol Infect 136 (2008) 1712-1716. 
  
 
 
Page  133 
 
  
[232] Sander A., Posselt M., Oberle K., Bredt W.: Seroprevalence of antibodies to 
Bartonella henselae in patients with cat scratch disease and in healthy controls: 
evaluation and comparison of two commercial serological tests. Clin Diagn Lab 
Immunol 5 (1998) 486-490. 
[233] Tea A., Alexiou-Daniel S., Arvanitidou M., Diza E., Antoniadis A.: Occurrence of 
Bartonella henselae and Bartonella quintana in a healthy Greek population. Am 
J Trop Med Hyg 68 (2003) 554-556. 
[234] Garcia-Garcia J. A., Baquerizo R., Vargas J., Mira J. A., Merchante N., Macias J., 
Pineda J. A.: [Prevalence of serum antibodies against Bartonella ssp. in a health 
population from the south area of the Seville province]. Rev Clin Esp 205 (2005) 
541-544. 
[235] McGill S., Wesslen L., Hjelm E., Holmberg M., Auvinen M. K., Berggren K., 
Grandin-Jarl B., Johnson U., Wikstrom S., Friman G.: Bartonella spp. 
seroprevalence in healthy Swedish blood donors. Scand J Infect Dis 37 (2005) 
723-730. 
[236] Blanco Ramos J. R., Oteo Revuelta J. A., Martinez de Artola V., Ramalle Gomara 
E., Garcia Pineda A., Ibarra Cucalon V.: [Seroepidemiology of Bartonella henselae 
infection in a risk group]. Rev Clin Esp 198 (1998) 805-809. 
[237] Jacomo V., Kelly P.J., Raoult D.: Natural history of Bartonella infections (an 
exception to Koch's postulate). Clin Diagn Lab Immunol 9 (2002) 8-18. 
[238] Kruszewska D., Tylewska-Wierzbanowska S.: Unknown species of rickettsiae 
isolated from Ixodes ricinus tick in Walcz. Rocz Akad Med Bialymst 41 (1996) 
129-135. 
[239] Lucey D., Dolan M. J., Moss C. W., Garcia M., Hollis D. G., Wegner S., Morgan G., 
Almeida R., Leong D., Greisen K. S., et al.: Relapsing illness due to Rochalimaea 
henselae in immunocompetent hosts: implication for therapy and new 
epidemiological associations. Clin Infect Dis 14 (1992) 683-688. 
 
 
 
 
 
 
  
 
 
Page  134 
 
  
9. Curriculum vitae 
 
1979.03.22  in Klagenfurt, Kärnten, Österreich 
1985 bis 1989 Besuch der Volkschule Klagenfurt – Viktring 
1989 bis 1997 Besuch des Bundesrealgymnasiums Klagenfurt – Viktring 
1997 Matura im naturwissenschaftlichen Zweig 
1997 bis 1998 Wehrdienst mit Ausbildung zum Rettungssanitäter 
1998 bis 2010 Diplomstudium Biologie, Universität Wien 
 Schwerpunkt Genetik / Mikrobiologie 
 Spezialisierung Immunologie 
2000 bis 2006 Arbeit als Outdoor – Experience Trainer in Degi’s Abenteuerschule 
 Mürzsteg, Steiermark 
2001/08 bis 2001/09 Labortätigkeit, Firma Clariant, Burgkirchen, Deutschland 
2002/08 und 2003/08 Labortätigkeit, Firma Baxter – Serologie, Wien 
WS 2007/08/09 Tutor, Medizinische Universität Wien 
 MCW Mikrobiologie und Parasitologie 
SS 2009/10 Mitarbeiter, Kinderuni Wien 
